Constitutive	O
overexpression	O
of	O
the	O
L-selectin	B-DNA
gene	I-DNA
in	O
fresh	O
leukemic	B-cell_type
cells	I-cell_type
of	O
adult	O
T-cell	O
leukemia	O
that	O
can	O
be	O
transactivated	O
by	O
human	B-protein
T-cell	I-protein
lymphotropic	I-protein
virus	I-protein
type	I-protein
1	I-protein
Tax	I-protein
.	O

L-selectin	B-protein
is	O
an	O
adhesion	O
molecule	O
of	O
the	O
selectin	O
family	O
that	O
mediates	O
the	O
initial	O
step	O
of	O
leukocyte	O
adhesion	O
to	O
vascular	O
endothelium	O
.	O

Upon	O
cellular	O
activation	O
,	O
expression	O
of	O
the	O
L-selectin	B-DNA
gene	I-DNA
is	O
downregulated	O
at	O
both	O
the	O
protein	O
and	O
mRNA	O
levels	O
.	O

To	O
understand	O
the	O
mechanism	O
of	O
leukemic	B-cell_type
cell	I-cell_type
infiltration	O
into	O
organs	O
,	O
we	O
studied	O
the	O
expression	O
and	O
regulation	O
of	O
L-selectin	B-RNA
mRNA	I-RNA
in	O
fresh	O
leukemic	B-cell_type
cells	I-cell_type
of	O
adult	O
T-cell	O
leukemia	O
(	O
ATL	O
)	O
patients	O
and	O
investigated	O
the	O
response	O
of	O
the	O
L-selectin	B-DNA
promoter	I-DNA
to	O
human	B-protein
T-cell	I-protein
lymphotropic	I-protein
virus	I-protein
type	I-protein
1	I-protein
(	I-protein
HTLV-1	I-protein
)	I-protein
Tax	I-protein
,	O
which	O
is	O
a	O
viral	B-protein
transcriptional	I-protein
transactivator	I-protein
.	O

Flow	O
cytometry	O
showed	O
that	O
L-selectin	B-protein
was	O
expressed	O
on	O
fresh	O
ATL	B-cell_line
cells	I-cell_line
along	O
with	O
other	O
activation	B-protein
antigens	I-protein
.	O

Northern	O
blot	O
analysis	O
showed	O
that	O
ATL	B-cell_line
cells	I-cell_line
overexpressed	O
that	O
L-selectin	B-RNA
mRNA	I-RNA
and	O
that	O
the	O
level	O
was	O
aberrantly	O
upregulated	O
after	O
PMA	O
stimulation	O
.	O

Studies	O
using	O
in	O
situ	O
hybridization	O
showed	O
expression	O
of	O
the	O
L-selectin	B-RNA
mRNA	I-RNA
in	O
the	O
infiltrating	O
leukemic	B-cell_type
cells	I-cell_type
in	O
the	O
liver	O
of	O
two	O
ATL	O
patients	O
.	O

Intravenous	O
injection	O
of	O
a	O
rat	B-cell_line
T-cell	I-cell_line
line	I-cell_line
that	O
overexpresses	O
L-selectin	B-protein
showed	O
increased	O
organ	O
infiltration	O
.	O

The	O
induction	O
of	O
Tax	B-protein
expression	O
in	O
JPX9	B-cell_line
cells	I-cell_line
resulted	O
in	O
about	O
a	O
twofold	O
increase	O
in	O
the	O
mRNA	B-RNA
expression	O
levels	O
compared	O
with	O
the	O
basal	O
level	O
.	O

Chloramphenicol	B-protein
acetyltransferase	I-protein
(	O
CAT	B-protein
)	O
assay	O
after	O
transient	O
cotransfection	O
showed	O
about	O
a	O
fivefold	O
transactivation	O
of	O
the	O
L-selectin	B-DNA
promoter	I-DNA
by	O
Tax	B-protein
.	O

The	O
serum	O
level	O
of	O
the	O
shed	O
form	O
of	O
L-selectin	B-protein
was	O
significantly	O
increased	O
in	O
ATL	O
patients	O
(	O
mean	O
+/-	O
SD	O
,	O
4	O
,	O
215.4	O
+/-	O
4	O
,	O
111	O
ng/mL	O
)	O
compared	O
with	O
those	O
of	O
asymptomatic	O
carriers	O
and	O
healthy	O
blood	O
donors	O
(	O
mean	O
+/-	O
SD	O
,	O
1	O
,	O
148.0	O
+/-	O
269.0	O
ng/mL	O
and	O
991.9	O
+/-	O
224	O
ng/mL	O
,	O
respectively	O
)	O
.	O

These	O
results	O
indicated	O
that	O
ATL	B-cell_line
cells	I-cell_line
constitutively	O
overexpress	O
the	O
L-selectin	B-DNA
gene	I-DNA
that	O
can	O
be	O
transactivated	O
by	O
HTLV-1	O
Tax	B-protein
.	O

The	O
overexpression	O
of	O
L-selectin	B-protein
,	O
as	O
well	O
as	O
of	O
inflammatory	B-protein
cytokines	I-protein
,	O
by	O
ATL	B-cell_line
cells	I-cell_line
may	O
provide	O
a	O
basis	O
for	O
ATL	B-cell_line
cells	I-cell_line
to	O
attach	O
the	O
vascular	O
endothelium	O
,	O
leading	O
to	O
transmigration	O
and	O
organ	O
infitration	O
.	O

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Constitutive	NULL
Overexpression	NULL
of	NULL
the	NULL
L-Selectin	NULL
Gene	NULL
in	NULL
Fresh	NULL
Leukemic	NULL
Cells	NULL
of	NULL
Adult	NULL
T-Cell	NULL
Leukemia	NULL
That	NULL
Can	NULL
Be	NULL
Transactivated	NULL
by	NULL
Human	NULL
T-Cell	NULL
Lymphotropic	NULL
Virus	NULL
Type	NULL
1	NULL
Tax	NULL
By	NULL
Makoto	NULL
Tatewaki	NULL
,	NULL
Kazunari	NULL
Yamaguchi	NULL
,	NULL
Masao	NULL
Matsuoka	NULL
,	NULL
Toshinori	NULL
Ishii	NULL
,	NULL
Masayuki	NULL
Miyasaka	NULL
,	NULL
Shigeo	NULL
Mori	NULL
,	NULL
Kiyoshi	NULL
Takatsuki	NULL
,	NULL
and	NULL
Toshiki	NULL
Watanabe	NULL
L-selectin	NULL
is	NULL
an	NULL
adhesion	NULL
molecule	NULL
of	NULL
the	NULL
selectin	NULL
family	NULL
that	NULL
mediates	NULL
the	NULL
initial	NULL
step	NULL
of	NULL
leukocyte	NULL
adhesion	NULL
to	NULL
vascular	NULL
endothelium	NULL
.	NULL

Upon	NULL
cellular	NULL
activation	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
L-selectin	NULL
gene	NULL
is	NULL
downregulated	NULL
at	NULL
both	NULL
the	NULL
protein	NULL
and	NULL
mRNA	NULL
levels	NULL
.	NULL

To	NULL
understand	NULL
the	NULL
mechanism	NULL
of	NULL
leukemic	NULL
cell	NULL
infiltration	NULL
into	NULL
organs	NULL
,	NULL
we	NULL
studied	NULL
the	NULL
expression	NULL
and	NULL
regulation	NULL
of	NULL
L-selectin	NULL
mRNA	NULL
in	NULL
fresh	NULL
leukemic	NULL
cells	NULL
of	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
(	NULL
ATL	NULL
)	NULL
patients	NULL
and	NULL
investigated	NULL
the	NULL
response	NULL
of	NULL
the	NULL
L-selectin	NULL
promoter	NULL
to	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
Tax	NULL
,	NULL
which	NULL
is	NULL
a	NULL
viral	NULL
transcriptional	NULL
transactivator	NULL
,	NULL
Flow	NULL
cytometry	NULL
showed	NULL
that	NULL
L-selectin	NULL
was	NULL
expressed	NULL
on	NULL
fresh	NULL
ATL	NULL
cells	NULL
along	NULL
with	NULL
other	NULL
activation	NULL
antigens	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
showed	NULL
that	NULL
ATL	NULL
cells	NULL
overexpressed	NULL
the	NULL
L-selectin	NULL
mRNA	NULL
and	NULL
that	NULL
the	NULL
level	NULL
was	NULL
aber-rantly	NULL
upregulated	NULL
after	NULL
PMA	NULL
stimulation	NULL
.	NULL

Studies	NULL
using	NULL
in	NULL
situ	NULL
hybridization	NULL
showed	NULL
expression	NULL
of	NULL
the	NULL
L-selectin	NULL
mRNA	NULL
in	NULL
the	NULL
infiltrating	NULL
leukemic	NULL
cells	NULL
in	NULL
the	NULL
liver	NULL
of	NULL
two	NULL
ATL	NULL
patients	NULL
.	NULL

Intravenous	NULL
injection	NULL
of	NULL
a	NULL
rat	NULL
T-cell	NULL
line	NULL
that	NULL
DULT	NULL
T-CELL	NULL
LEUKEMIA	NULL
(	NULL
ATL	NULL
)	NULL
is	NULL
an	NULL
aggressive	NULL
,	NULL
usually	NULL
fatal	NULL
T-cell	NULL
malignancy	NULL
that	NULL
is	NULL
caused	NULL
by	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
infection	NULL
.	NULL
``	NULL

ATL	NULL
is	NULL
also	NULL
characterized	NULL
by	NULL
unique	NULL
clinical	NULL
features	NULL
such	NULL
as	NULL
a	NULL
very	NULL
high	NULL
frequency	NULL
of	NULL
hypercalcemia	NULL
and	NULL
a	NULL
remarkable	NULL
tendency	NULL
of	NULL
organ	NULL
infiltration	NULL
by	NULL
leukemic	NULL
cells	NULL
into	NULL
the	NULL
liver	NULL
,	NULL
spleen	NULL
,	NULL
lungs	NULL
,	NULL
and	NULL
skin	NULL
.	NULL
``	NULL

''	NULL
HTLV-1	NULL
is	NULL
also	NULL
associated	NULL
with	NULL
chronic	NULL
inflammatory	NULL
disorders	NULL
such	NULL
as	NULL
tropical	NULL
spastic	NULL
parapa-resis	NULL
/HTLV-1	NULL
-associated	NULL
myelopathy	NULL
(	NULL
TSP/HAM	NULL
)	NULL
,	NULL
HTLV-I	NULL
uveitis	NULL
(	NULL
HU	NULL
)	NULL
,	NULL
alveolitis	NULL
,	NULL
and	NULL
others	NULL
.	NULL
``	NULL

''	NULL
Infiltration	NULL
of	NULL
mononuclear	NULL
cells	NULL
and	NULL
HTLV-1-infected	NULL
T	NULL
cells	NULL
is	NULL
also	NULL
a	NULL
characteristic	NULL
commonly	NULL
found	NULL
in	NULL
these	NULL
HTLV-1	NULL
-associated	NULL
diseases	NULL
.	NULL

Spinal	NULL
cord	NULL
lesions	NULL
of	NULL
patients	NULL
with	NULL
TSP/HAM	NULL
are	NULL
characterized	NULL
by	NULL
demyelination	NULL
accompanied	NULL
by	NULL
mononuclear	NULL
cell	NULL
infiltration	NULL
and	NULL
perivascular	NULL
cuffing	NULL
.	NULL
``	NULL

In	NULL
the	NULL
aqueous	NULL
humor	NULL
of	NULL
the	NULL
patients	NULL
with	NULL
HU	NULL
,	NULL
the	NULL
infiltrating	NULL
cells	NULL
consisted	NULL
mostly	NULL
of	NULL
lymphocytes	NULL
with	NULL
a	NULL
predominance	NULL
of	NULL
T	NULL
cells	NULL
and	NULL
the	NULL
HTLV-1-infected	NULL
cells	NULL
were	NULL
almost	NULL
universally	NULL
present	NULL
among	NULL
them	NULL
.	NULL

*	NULL
``	NULL
Thus	NULL
,	NULL
the	NULL
infiltration	NULL
of	NULL
lymphocytes	NULL
in	NULL
various	NULL
organs	NULL
could	NULL
be	NULL
one	NULL
of	NULL
the	NULL
common	NULL
pathologic	NULL
findings	NULL
among	NULL
diseases	NULL
associated	NULL
with	NULL
HTLV-1	NULL
infection	NULL
.	NULL

L-selectin	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
selectin	NULL
family	NULL
of	NULL
adhesion	NULL
molecules	NULL
.	NULL
``	NULL

It	NULL
is	NULL
expressed	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
most	NULL
leuko-cytes	NULL
,	NULL
including	NULL
lymphocytes	NULL
,	NULL
neutrophils	NULL
,	NULL
monocytes	NULL
,	NULL
eosin-ophils	NULL
,	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
,	NULL
and	NULL
immature	NULL
thymo-cytes	NULL
.	NULL

L-selectin	NULL
is	NULL
a	NULL
highly	NULL
glycosylated	NULL
protein	NULL
of	NULL
95	NULL
to	NULL
105	NULL
kD	NULL
on	NULL
neutrophils	NULL
and	NULL
of	NULL
74	NULL
kD	NULL
on	NULL
lymphocytes	NULL
.	NULL

It	NULL
is	NULL
thought	NULL
to	NULL
mediate	NULL
lymphocyte	NULL
recirculation	NULL
to	NULL
the	NULL
peripheral	NULL
lymph	NULL
node	NULL
,	NULL
specifically	NULL
recognizing	NULL
high	NULL
endothelial	NULL
ve-nules	NULL
in	NULL
lymph	NULL
nodes	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
L-selectin	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
adhesion	NULL
of	NULL
neutrophils	NULL
,	NULL
monocytes	NULL
,	NULL
and	NULL
lymphocytes	NULL
to	NULL
activated	NULL
endothelium	NULL
at	NULL
sites	NULL
of	NULL
inflammation	NULL
.	NULL

Extravasation	NULL
of	NULL
circulating	NULL
lymphocytes	NULL
consists	NULL
of	NULL
three	NULL
steps	NULL
``	NULL
``	NULL
:	NULL
rolling	NULL
mediated	NULL
by	NULL
selectins	NULL
,	NULL
sticking	NULL
by	NULL
integrins	NULL
,	NULL
and	NULL
transendo-thelial	NULL
migration	NULL
.	NULL

L-selectin	NULL
is	NULL
considered	NULL
to	NULL
mediate	NULL
the	NULL
initial	NULL
attachment	NULL
of	NULL
lymphocytes	NULL
to	NULL
endothelium	NULL
,	NULL
which	NULL
determines	NULL
the	NULL
stickiness	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

After	NULL
cellular	NULL
activation	NULL
,	NULL
this	NULL
molecule	NULL
rapidly	NULL
disappears	NULL
Blood	NULL
,	NULL
Vol	NULL
86	NULL
,	NULL
No	NULL
8	NULL
(	NULL
October	NULL
15	NULL
}	NULL
,	NULL
1995	NULL
;	NULL
pp	NULL
3109-3117	NULL
overexpresses	NULL
L-selectin	NULL
showed	NULL
increased	NULL
organ	NULL
infiltra-tion	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
Tax	NULL
expression	NULL
in	NULL
JPX9	NULL
cells	NULL
resulted	NULL
in	NULL
about	NULL
a	NULL
twofold	NULL
increase	NULL
in	NULL
the	NULL
mRNA	NULL
expression	NULL
levels	NULL
compared	NULL
with	NULL
the	NULL
basal	NULL
level	NULL
.	NULL

Chloramphenicol	NULL
acetylitrans-ferase	NULL
(	NULL
CAT	NULL
)	NULL
}	NULL
assay	NULL
after	NULL
transient	NULL
cotransfection	NULL
showed	NULL
about	NULL
a	NULL
fivefold	NULL
transactivation	NULL
of	NULL
the	NULL
L-selectin	NULL
promoter	NULL
by	NULL
Tax	NULL
.	NULL

The	NULL
serum	NULL
level	NULL
of	NULL
the	NULL
shed	NULL
form	NULL
of	NULL
L-selectin	NULL
was	NULL
significantly	NULL
increased	NULL
in	NULL
ATL	NULL
patients	NULL
{	NULL
mean	NULL
+	NULL
SD	NULL
,	NULL
4,215.4	NULL
+	NULL
4,111	NULL
ng/mL	NULL
}	NULL
compared	NULL
with	NULL
those	NULL
of	NULL
asymptomatic	NULL
carriers	NULL
and	NULL
healthy	NULL
biood	NULL
donors	NULL
{	NULL
mean	NULL
+	NULL
SD	NULL
,	NULL
1,148.0	NULL
+	NULL
269.0	NULL
ng/	NULL
mL	NULL
and	NULL
991.9	NULL
+	NULL
224	NULL
ng/mL	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
ATL	NULL
cells	NULL
constitutively	NULL
overexpress	NULL
the	NULL
L-selectin	NULL
gene	NULL
that	NULL
can	NULL
be	NULL
transactivated	NULL
by	NULL
HTLV-1	NULL
Tax	NULL
.	NULL

The	NULL
overexpression	NULL
of	NULL
L-selectin	NULL
,	NULL
as	NULL
well	NULL
as	NULL
of	NULL
inflammatory	NULL
cytokines	NULL
,	NULL
by	NULL
ATL	NULL
cells	NULL
may	NULL
provide	NULL
a	NULL
basis	NULL
for	NULL
ATL	NULL
cells	NULL
to	NULL
attach	NULL
the	NULL
vascular	NULL
endothelium	NULL
,	NULL
leading	NULL
to	NULL
transmigration	NULL
and	NULL
organ	NULL
infitration	NULL
.	NULL

©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

from	NULL
the	NULL
cell	NULL
surface	NULL
by	NULL
shedding	NULL
``	NULL
and	NULL
transcription	NULL
of	NULL
the	NULL
mRNA	NULL
is	NULL
also	NULL
downregulated	NULL
by	NULL
18	NULL
to	NULL
24	NULL
hours	NULL
.	NULL
``	NULL

''	NULL
This	NULL
downregulation	NULL
is	NULL
thought	NULL
to	NULL
prepare	NULL
the	NULL
extravasated	NULL
cells	NULL
for	NULL
transmigration	NULL
into	NULL
tissues	NULL
.	NULL

The	NULL
extracellular	NULL
domain	NULL
is	NULL
proteolytically	NULL
shed	NULL
from	NULL
the	NULL
cell	NULL
surface	NULL
``	NULL
``	NULL
and	NULL
the	NULL
shed	NULL
form	NULL
of	NULL
L-selectin	NULL
(	NULL
sL-selectin	NULL
)	NULL
is	NULL
present	NULL
at	NULL
a	NULL
relatively	NULL
high	NULL
concentration	NULL
in	NULL
the	NULL
normal	NULL
serum	NULL
,	NULL
in	NULL
which	NULL
it	NULL
is	NULL
functionally	NULL
active	NULL
,	NULL
inhibiting	NULL
leukocyte	NULL
attachment	NULL
to	NULL
the	NULL
endothelium	NULL
at	NULL
high	NULL
concentrations	NULL
.	NULL
``	NULL

Thus	NULL
,	NULL
the	NULL
regulation	NULL
of	NULL
L-selectin	NULL
expression	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
as	NULL
well	NULL
as	NULL
in	NULL
protein	NULL
processing	NULL
appears	NULL
to	NULL
be	NULL
an	NULL
important	NULL
determinant	NULL
of	NULL
physiologic	NULL
and	NULL
pathologic	NULL
manifestations	NULL
of	NULL
the	NULL
function	NULL
of	NULL
this	NULL
adhesion	NULL
molecule	NULL
.	NULL

HTLV-1	NULL
has	NULL
a	NULL
transcriptional	NULL
activator	NULL
,	NULL
Tax	NULL
,	NULL
that	NULL
regulates	NULL
viral	NULL
replication	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
.	NULL
``	NULL

''	NULL
Transactivation	NULL
of	NULL
the	NULL
viral	NULL
genes	NULL
by	NULL
Tax	NULL
is	NULL
mediated	NULL
through	NULL
three	NULL
repeats	NULL
of	NULL
a	NULL
21-bp	NULL
enhancer	NULL
in	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
.	NULL
``	NULL

Because	NULL
Tax	NULL
can	NULL
not	NULL
directly	NULL
bind	NULL
to	NULL
the	NULL
enhancer	NULL
sequence	NULL
,	NULL
the	NULL
cellular	NULL
transcription	NULL
factors	NULL
are	NULL
thought	NULL
to	NULL
mediate	NULL
the	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
The	NULL
Institute	NULL
of	NULL
Medical	NULL
Science	NULL
,	NULL
The	NULL
University	NULL
of	NULL
Tokyo	NULL
,	NULL
Tokyo	NULL
;	NULL
the	NULL
Second	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
Kumamoto	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Kuma-moto	NULL
;	NULL
and	NULL
the	NULL
Division	NULL
of	NULL
Organ	NULL
Bioregulation	NULL
,	NULL
Biomedical	NULL
Research	NULL
Center	NULL
,	NULL
Osaka	NULL
University	NULL
Medical	NULL
School	NULL
,	NULL
Osaka	NULL
,	NULL
Japan	NULL
.	NULL

Submitted	NULL
December	NULL
30	NULL
,	NULL
1994	NULL
;	NULL
accepted	NULL
June	NULL
5	NULL
,	NULL
1995	NULL
.	NULL

Supported	NULL
in	NULL
part	NULL
by	NULL
a	NULL
Grant	NULL
in	NULL
Aid	NULL
for	NULL
Scientific	NULL
Research	NULL
to	NULL
T.W	NULL
.	NULL

and	NULL
a	NULL
Grant	NULL
in	NULL
Aid	NULL
for	NULL
Cancer	NULL
Research	NULL
to	NULL
T.W	NULL
.	NULL

and	NULL
K.Y	NULL
.	NULL

from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Science	NULL
and	NULL
Culture	NULL
,	NULL
Japan	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Toshiki	NULL
Watanabe	NULL
,	NULL
MD	NULL
,	NULL
PhD	NULL
,	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
The	NULL
Institute	NULL
of	NULL
Medical	NULL
Science	NULL
,	NULL
The	NULL
University	NULL
of	NULL
Tokyo	NULL
,	NULL
4-6-1	NULL
Shirokanedai	NULL
,	NULL
Minatoku	NULL
,	NULL
Tokyo	NULL
108	NULL
,	NULL
Japan	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
``	NULL
advertisement	NULL
``	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-497	NULL
1/95/8608-0007	NULL
$	NULL
3.00/0	NULL
3109	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3110	NULL
transactivation	NULL
.	NULL
``	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
viral	NULL
genes	NULL
,	NULL
Tax	NULL
induces	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
cellular	NULL
transcription	NULL
factor	NULL
genes	NULL
``	NULL
that	NULL
are	NULL
controlled	NULL
by	NULL
transmembrane	NULL
signals	NULL
and	NULL
also	NULL
some	NULL
genes	NULL
that	NULL
encode	NULL
cytokines	NULL
and	NULL
their	NULL
receptors	NULL
.	NULL
``	NULL

Some	NULL
of	NULL
the	NULL
genes	NULL
that	NULL
can	NULL
be	NULL
transactivated	NULL
by	NULL
Tax	NULL
are	NULL
constitutively	NULL
expressed	NULL
in	NULL
ATL	NULL
cells	NULL
that	NULL
modulate	NULL
clinical	NULL
features	NULL
.	NULL
``	NULL

''	NULL
ATL	NULL
cells	NULL
have	NULL
a	NULL
membrane	NULL
phenotype	NULL
of	NULL
activated	NULL
CD4*	NULL
T	NULL
cells	NULL
,	NULL
expressing	NULL
interleukin-2	NULL
receptor	NULL
a	NULL
(	NULL
IL-2Ra	NULL
)	NULL
,	NULL
HLA-DR	NULL
,	NULL
and	NULL
other	NULL
activated	NULL
cell	NULL
antigens	NULL
.	NULL
``	NULL

''	NULL
``	NULL
'	NULL
The	NULL
data	NULL
of	NULL
Ishikawa	NULL
et	NULL
al	NULL
.	NULL

suggested	NULL
that	NULL
ATL	NULL
cells	NULL
are	NULL
characterized	NULL
as	NULL
CD4*	NULL
Leu-8*	NULL
T	NULL
cells	NULL
.	NULL
``	NULL

Because	NULL
Leu-8	NULL
antigen	NULL
is	NULL
identical	NULL
to	NULL
L-selectin	NULL
,	NULL
ATL	NULL
cells	NULL
express	NULL
typical	NULL
activation	NULL
antigens	NULL
and	NULL
L-selectin	NULL
at	NULL
the	NULL
same	NULL
time	NULL
,	NULL
which	NULL
suggests	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
L-selectin	NULL
expression	NULL
is	NULL
aberrant	NULL
.	NULL

We	NULL
studied	NULL
the	NULL
expression	NULL
of	NULL
L-selectin	NULL
in	NULL
ATL	NULL
cells	NULL
and	NULL
tested	NULL
the	NULL
regulation	NULL
of	NULL
its	NULL
gene	NULL
expression	NULL
by	NULL
HTLV-1	NULL
Tax	NULL
,	NULL
which	NULL
would	NULL
provide	NULL
a	NULL
clue	NULL
to	NULL
understanding	NULL
the	NULL
molecular	NULL
mechanism	NULL
of	NULL
L-selectin	NULL
gene	NULL
expression	NULL
and	NULL
leukemic	NULL
cell	NULL
infiltration	NULL
into	NULL
various	NULL
organs	NULL
in	NULL
ATL	NULL
patients	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Patients	NULL
plasma	NULL
and	NULL
cell	NULL
samples	NULL
.	NULL

ATL	NULL
was	NULL
diagnosed	NULL
according	NULL
to	NULL
the	NULL
described	NULL
criteria	NULL
.	NULL
``	NULL

Briefly	NULL
,	NULL
a	NULL
T-lymphocyte	NULL
neoplasm	NULL
that	NULL
resulted	NULL
from	NULL
the	NULL
monoclonal	NULL
expansion	NULL
of	NULL
HTLV-1-infected	NULL
T	NULL
cells	NULL
was	NULL
diagnosed	NULL
as	NULL
ATL	NULL
.	NULL

Seropositivity	NULL
against	NULL
HTLV-1	NULL
was	NULL
tested	NULL
using	NULL
a	NULL
PA	NULL
kit	NULL
(	NULL
Fujirebio	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
and	NULL
confirmed	NULL
using	NULL
an	NULL
enzyme	NULL
immunoassay	NULL
(	NULL
EIA	NULL
)	NULL
kit	NULL
(	NULL
Fizai	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

The	NULL
integration	NULL
of	NULL
HTLV-1	NULL
provirus	NULL
DNA	NULL
was	NULL
studied	NULL
using	NULL
Southern	NULL
blot-ting	NULL
.	NULL
``	NULL

Peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMCs	NULL
)	NULL
from	NULL
patients	NULL
with	NULL
ATL	NULL
and	NULL
normal	NULL
blood	NULL
donors	NULL
were	NULL
isolated	NULL
by	NULL
density	NULL
gradient	NULL
centrifugation	NULL
with	NULL
Ficoll	NULL
Pague	NULL
(	NULL
Pharmacia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
.	NULL

RNA	NULL
was	NULL
immediately	NULL
extracted	NULL
from	NULL
the	NULL
cells	NULL
or	NULL
they	NULL
were	NULL
quickly	NULL
frozen	NULL
in	NULL
liquid	NULL
nitrogen	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
until	NULL
use	NULL
.	NULL

Plasma	NULL
samples	NULL
were	NULL
collected	NULL
at	NULL
the	NULL
time	NULL
of	NULL
PBMC	NULL
preparation	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
until	NULL
use	NULL
.	NULL

Cell	NULL
lines	NULL
.	NULL

-	NULL
Jurkat	NULL
is	NULL
a	NULL
human	NULL
T-cell	NULL
line	NULL
established	NULL
from	NULL
T-ALL	NULL
cells	NULL
and	NULL
JPX-9	NULL
is	NULL
a	NULL
derivative	NULL
of	NULL
Jurkat	NULL
cells	NULL
carrying	NULL
the	NULL
transfected	NULL
Tax	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
metallothionein	NULL
promoter	NULL
.	NULL
``	NULL

MT-1	NULL
is	NULL
a	NULL
human	NULL
T-cell	NULL
line	NULL
derived	NULL
from	NULL
leukemic	NULL
cells	NULL
of	NULL
an	NULL
ATL	NULL
patient	NULL
.	NULL
``	NULL

These	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
and	NULL
antibiotics	NULL
.	NULL

FL	NULL
cells	NULL
were	NULL
derived	NULL
from	NULL
human	NULL
amnion	NULL
cells	NULL
``	NULL
``	NULL
and	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
and	NULL
antibiotics	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
Tax	NULL
in	NULL
JPX9	NULL
cells	NULL
was	NULL
induced	NULL
by	NULL
adding	NULL
20	NULL
umoI/L	NULL
CdCl	NULL
;	NULL
into	NULL
the	NULL
medium	NULL
.	NULL

Immunophenotyping	NULL
.	NULL

Cell	NULL
surface	NULL
markers	NULL
of	NULL
leukemic	NULL
cells	NULL
from	NULL
20	NULL
patients	NULL
with	NULL
ATL	NULL
(	NULL
13	NULL
with	NULL
acute	NULL
type	NULL
and	NULL
7	NULL
with	NULL
chronic	NULL
type	NULL
)	NULL
were	NULL
studied	NULL
and	NULL
those	NULL
of	NULL
normal	NULL
T	NULL
cells	NULL
from	NULL
9	NULL
blood	NULL
donors	NULL
served	NULL
as	NULL
controls	NULL
.	NULL

Heparinized	NULL
whole	NULL
blood	NULL
samples	NULL
were	NULL
immuno-phenotyped	NULL
without	NULL
PBMC	NULL
isolation	NULL
.	NULL

Cell	NULL
surface	NULL
antigens	NULL
were	NULL
detected	NULL
by	NULL
standard	NULL
immunofluorescence	NULL
using	NULL
a	NULL
panel	NULL
of	NULL
directly	NULL
fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
-	NULL
or	NULL
phycoerythrin-conjugated	NULL
monoclonal	NULL
antibodies	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
surface	NULL
antigens	NULL
was	NULL
studied	NULL
by	NULL
means	NULL
of	NULL
double	NULL
immunofluorescence	NULL
using	NULL
antibodies	NULL
that	NULL
react	NULL
with	NULL
CD3	NULL
,	NULL
CD4	NULL
,	NULL
CD8	NULL
,	NULL
CD25	NULL
,	NULL
and	NULL
Leu-8	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
;	NULL
Coulter	NULL
,	NULL
Hialeath	NULL
,	NULL
FL	NULL
)	NULL
.	NULL

Double	NULL
immunofluorescence	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
Spectrum	NULL
III	NULL
flow	NULL
cytometer	NULL
(	NULL
Ortho	NULL
,	NULL
West-wood	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

A	NULL
total	NULL
of	NULL
more	NULL
than	NULL
5,000	NULL
cells	NULL
were	NULL
analyzed	NULL
for	NULL
each	NULL
sample	NULL
.	NULL

Immunohistochemical	NULL
analysis	NULL
of	NULL
the	NULL
formalin-fixed	NULL
and	NULL
paraffin-embedded	NULL
tissues	NULL
was	NULL
performed	NULL
using	NULL
SAB	NULL
method	NULL
.	NULL
``	NULL

Analysis	NULL
of	NULL
L-selectin	NULL
gene	NULL
expression	NULL
.	NULL

-	NULL
Total	NULL
cytoplasmic	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
the	NULL
fresh	NULL
PBMCs	NULL
of	NULL
ATL	NULL
patients	NULL
and	NULL
cell	NULL
lines	NULL
TATEWAKI	NULL
ET	NULL
AL	NULL
using	NULL
the	NULL
vanadyl	NULL
ribonucleoside	NULL
complex	NULL
.	NULL
``	NULL

To	NULL
study	NULL
the	NULL
modulation	NULL
of	NULL
gene	NULL
expression	NULL
,	NULL
PBMC	NULL
samples	NULL
were	NULL
cultured	NULL
for	NULL
18	NULL
to	NULL
24	NULL
hours	NULL
with	NULL
or	NULL
without	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
;	NULL
10	NULL
ng/mL	NULL
)	NULL
and	NULL
then	NULL
cytoplasmic	NULL
RNA	NULL
was	NULL
extracted	NULL
.	NULL

Ten	NULL
micrograms	NULL
of	NULL
total	NULL
RNA	NULL
was	NULL
Northern	NULL
blotted	NULL
.	NULL

After	NULL
transfer	NULL
to	NULL
nylon	NULL
membranes	NULL
(	NULL
BioDyne	NULL
B	NULL
;	NULL
Pall	NULL
BioSupport	NULL
Corp	NULL
,	NULL
Glen	NULL
Cove	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
the	NULL
RNA	NULL
was	NULL
fixed	NULL
by	NULL
UV	NULL
irradiation	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
hybridized	NULL
with	NULL
probes	NULL
at	NULL
42°C	NULL
in	NULL
a	NULL
solution	NULL
containing	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
4x	NULL
SSC	NULL
,	NULL
10x	NULL
Denhardt	NULL
's	NULL
solution	NULL
,	NULL
0.1	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
,	NULL
and	NULL
100	NULL
ug/mL	NULL
of	NULL
denatured	NULL
salmon	NULL
sperm	NULL
DNA	NULL
.	NULL

An	NULL
L-selectin	NULL
cDNA	NULL
probe	NULL
covering	NULL
entire	NULL
protein	NULL
coding	NULL
sequence	NULL
was	NULL
prepared	NULL
using	NULL
reverse	NULL
transcrip-tion-polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
RT-PCR	NULL
)	NULL
and	NULL
cloning	NULL
into	NULL
the	NULL
pCRII	NULL
plasmid	NULL
by	NULL
means	NULL
of	NULL
TA	NULL
cloning	NULL
(	NULL
In	NULL
Vitrogen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
insert	NULL
cDNA	NULL
was	NULL
confirmed	NULL
by	NULL
sequencing	NULL
using	NULL
the	NULL
Sequenase	NULL
kit	NULL
(	NULL
US	NULL
Biochemicals	NULL
,	NULL
Cleaveland	NULL
,	NULL
OH	NULL
)	NULL
.	NULL

For	NULL
detection	NULL
of	NULL
L-selectin	NULL
mRNA	NULL
in	NULL
tissue	NULL
samples	NULL
,	NULL
we	NULL
performed	NULL
in	NULL
situ	NULL
hybridization	NULL
.	NULL

Samples	NULL
of	NULL
the	NULL
formalin-fixed	NULL
and	NULL
par-affin-embedded	NULL
liver	NULL
of	NULL
two	NULL
ATL	NULL
patients	NULL
and	NULL
a	NULL
biopsy	NULL
specimen	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
chronic	NULL
active	NULL
hepatitis	NULL
were	NULL
used	NULL
for	NULL
the	NULL
study	NULL
.	NULL

Serial	NULL
sections	NULL
of	NULL
4	NULL
to	NULL
6	NULL
um	NULL
were	NULL
prepared	NULL
on	NULL
the	NULL
slides	NULL
coated	NULL
with	NULL
3-aminopropyltriethoxysilane	NULL
.	NULL

Digoxigenin-labeled	NULL
antisense	NULL
and	NULL
sense	NULL
L-selectin	NULL
cRNA	NULL
probes	NULL
were	NULL
prepared	NULL
from	NULL
a	NULL
plasmid	NULL
containing	NULL
589bp	NULL
cDNA	NULL
fragment	NULL
(	NULL
nucleotide	NULL
position	NULL
998-1586	NULL
)	NULL
``	NULL
using	NULL
DIG	NULL
RNA	NULL
Labelling	NULL
Kit	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
Biochemica	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Hybridization	NULL
was	NULL
performed	NULL
at	NULL
37°C	NULL
for	NULL
12	NULL
hours	NULL
in	NULL
a	NULL
solution	NULL
containing	NULL
50	NULL
%	NULL
deionized	NULL
formamide	NULL
,	NULL
10	NULL
mmol/	NULL
L	NULL
Tris	NULL
HCl	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
10	NULL
%	NULL
dextran	NULL
sulfate	NULL
,	NULL
1	NULL
%	NULL
Denhardt	NULL
's	NULL
solution	NULL
,	NULL
600	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
1	NULL
%	NULL
SDS	NULL
,	NULL
and	NULL
200	NULL
ng/mL	NULL
DIG-labeled	NULL
cRNA	NULL
probe	NULL
.	NULL

After	NULL
hybridization	NULL
,	NULL
the	NULL
slides	NULL
were	NULL
rinsed	NULL
twice	NULL
in	NULL
a	NULL
solution	NULL
containing	NULL
2	NULL
%	NULL
SSC	NULL
and	NULL
0.1	NULL
%	NULL
SDS	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
5	NULL
minutes	NULL
and	NULL
once	NULL
in	NULL
a	NULL
solution	NULL
containing	NULL
0.2	NULL
%	NULL
SSC	NULL
and	NULL
0.1	NULL
%	NULL
SDS	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
5	NULL
minutes	NULL
.	NULL

Detection	NULL
of	NULL
the	NULL
hybridization	NULL
was	NULL
performed	NULL
using	NULL
DIG	NULL
Nucleic	NULL
Acid	NULL
Detection	NULL
Kit	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
Biochemica	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Analysis	NULL
of	NULL
organ	NULL
infiltration	NULL
by	NULL
an	NULL
L-selectin-overexressing	NULL
rat	NULL
T-cell	NULL
line	NULL
.	NULL

-	NULL
An	NULL
expression	NULL
vector	NULL
for	NULL
the	NULL
rat	NULL
L-selectin	NULL
was	NULL
constructed	NULL
using	NULL
BCMGSNeo	NULL
vector	NULL
``	NULL
and	NULL
an	NULL
HTLV-1/infected	NULL
rat	NULL
T-cell	NULL
line	NULL
TARL-2	NULL
,	NULL
**	NULL
which	NULL
does	NULL
not	NULL
express	NULL
L-selectin	NULL
,	NULL
was	NULL
transformed	NULL
and	NULL
selected	NULL
by	NULL
neomycin	NULL
.	NULL

Expression	NULL
of	NULL
L-selectin	NULL
by	NULL
the	NULL
transformed	NULL
cell	NULL
line	NULL
was	NULL
confirmed	NULL
by	NULL
Nothern	NULL
blotting	NULL
and	NULL
flow	NULL
cytometry	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

About	NULL
1	NULL
x	NULL
10°	NULL
cells	NULL
of	NULL
the	NULL
L-selectin-overexpressing	NULL
TARL-2	NULL
[	NULL
TARL-2	NULL
L	NULL
(	NULL
+	NULL
)	NULL
]	NULL
and	NULL
the	NULL
original	NULL
cell	NULL
line	NULL
were	NULL
labeled	NULL
by	NULL
FITC	NULL
and	NULL
injected	NULL
into	NULL
WKAH	NULL
rat	NULL
intravenously	NULL
.	NULL

Two	NULL
hours	NULL
after	NULL
injection	NULL
,	NULL
an	NULL
immunohistichemical	NULL
study	NULL
was	NULL
performed	NULL
using	NULL
anti-FITC	NULL
antibody	NULL
(	NULL
DAKOPATTS	NULL
A/S	NULL
,	NULL
Glostrup	NULL
,	NULL
Denmark	NULL
)	NULL
and	NULL
SAB	NULL
method	NULL
.	NULL
``	NULL

Plasmid	NULL
,	NULL
transfections	NULL
,	NULL
and	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
assays	NULL
.	NULL

_	NULL
L-selectin	NULL
promoter-CAT	NULL
plasmid	NULL
,	NULL
pLS-1	NULL
CAT	NULL
,	NULL
has	NULL
a	NULL
genomic	NULL
fragment	NULL
of	NULL
about	NULL
900-bp	NULL
that	NULL
flanks	NULL
the	NULL
5	NULL
``	NULL
end	NULL
of	NULL
exon	NULL
2	NULL
of	NULL
the	NULL
L-selectin	NULL
gene	NULL
.	NULL
``	NULL

The	NULL
L-selectin	NULL
promoter	NULL
has	NULL
been	NULL
identified	NULL
and	NULL
characterized	NULL
(	NULL
Tatewaki	NULL
et	NULL
al	NULL
,	NULL
submitted	NULL
for	NULL
publication	NULL
)	NULL
.	NULL

Transcriptional	NULL
transactivation	NULL
was	NULL
tested	NULL
by	NULL
transient	NULL
cotransfection	NULL
assays	NULL
using	NULL
a	NULL
Tax	NULL
expression	NULL
plasmid	NULL
.	NULL
``	NULL

FL	NULL
and	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
using	NULL
CaPO	NULL
,	NULL
precipitation	NULL
and	NULL
diethyl	NULL
aminoethyl	NULL
(	NULL
DEAE	NULL
)	NULL
-dextran	NULL
,	NULL
respectively	NULL
.	NULL
``	NULL

About	NULL
1	NULL
x	NULL
10	NULL
``	NULL
cells	NULL
of	NULL
each	NULL
type	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
CAT	NULL
reporter	NULL
plasmids	NULL
,	NULL
together	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
the	NULL
Tax	NULL
expression	NULL
vector	NULL
.	NULL

After	NULL
48	NULL
hours	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
extracts	NULL
were	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Gorman	NULL
et	NULL
al	NULL
,	NULL
``	NULL
except	NULL
the	NULL
radioactivity	NULL
was	NULL
measured	NULL
by	NULL
Bio	NULL
Image	NULL
Analyzer	NULL
,	NULL
BA1OO	NULL
(	NULL
Fuji	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
}	NULL
.	NULL

The	NULL
pB-Gal	NULL
plasmid	NULL
was	NULL
cotransfected	NULL
to	NULL
monitor	NULL
the	NULL
efficiency	NULL
of	NULL
transfection	NULL
and	NULL
CAT	NULL
activity	NULL
was	NULL
corrected	NULL
by	NULL
the	NULL
activity	NULL
of	NULL
3-Gal	NULL
in	NULL
each	NULL
experi-ment	NULL
.	NULL

Quantitation	NULL
of	NULL
the	NULL
serum	NULL
level	NULL
of	NULL
sL-selectin	NULL
and	NULL
sIL-2Ra	NULL
.	NULL

Serum	NULL
levels	NULL
of	NULL
the	NULL
shed	NULL
form	NULL
L-selectin	NULL
(	NULL
sL-selectin	NULL
)	NULL
were	NULL
quantified	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

OVEREXPRESSION	NULL
OF	NULL
L-SELECTIN	NULL
IN	NULL
ATL	NULL
Table	NULL
1	NULL
.	NULL

Leu-8	NULL
Expression	NULL
in	NULL
the	NULL
Peripheral	NULL
Blood	NULL
of	NULL
ATL	NULL
Patients	NULL
and	NULL
Normal	NULL
Controls	NULL
Case	NULL
No	NULL
.	NULL

Type	NULL
CD4®	NULL
Leu8	NULL
?	NULL

Leu-8*/CD4®	NULL
1	NULL
Acute	NULL
92.6	NULL
17.7	NULL
%	NULL
24.8	NULL
2	NULL
Acute	NULL
86.4	NULL
68.1*	NULL
75.9	NULL
3	NULL
Acute	NULL
73.6	NULL
85.0*	NULL
63.8	NULL
4	NULL
Acute	NULL
80.2	NULL
57.9*	NULL
44.9	NULL
5	NULL
Acute	NULL
89.6	NULL
69.3*	NULL
47.1	NULL
6	NULL
Acute	NULL
96.5	NULL
44.9*	NULL
57.6	NULL
7	NULL
Acute	NULL
64.1	NULL
68.8*	NULL
55.9	NULL
8	NULL
Acute	NULL
95.6	NULL
63.6*	NULL
78.5	NULL
9	NULL
Acute	NULL
97.7	NULL
53.4*	NULL
65.6	NULL
10	NULL
Acute	NULL
86.4	NULL
1.8*	NULL
53.3	NULL
11	NULL
Acute	NULL
94.4	NULL
84.8*	NULL
86.9	NULL
12	NULL
Acute	NULL
77.2	NULL
1716*	NULL
73.8	NULL
13	NULL
Acute	NULL
84.2	NULL
54.0*	NULL
51.7	NULL
14	NULL
Chronic	NULL
91.0	NULL
85.1*	NULL
84.3	NULL
15	NULL
Chronic	NULL
92.3	NULL
4.8	NULL
90.3	NULL
16	NULL
Chronic	NULL
94.6	NULL
82.5*	NULL
84.1	NULL
17	NULL
Chronic	NULL
66.0	NULL
69.9*	NULL
62.8	NULL
18	NULL
Chronic	NULL
96.4	NULL
79.4*	NULL
87.0	NULL
19	NULL
Chronic	NULL
71.6	NULL
63.5*	NULL
59.2	NULL
20	NULL
Chronic	NULL
97.2	NULL
88.7*	NULL
ND	NULL
21	NULL
Control	NULL
48.3	NULL
70.1	NULL
43.6	NULL
22	NULL
Control	NULL
46.4	NULL
81.2	NULL
41.0	NULL
28	NULL
Control	NULL
37.8	NULL
70.7	NULL
31.1	NULL
24	NULL
Control	NULL
47.1	NULL
79.1	NULL
43.3	NULL
25	NULL
Control	NULL
30.9	NULL
69.5	NULL
25.1	NULL
26	NULL
Control	NULL
47.1	NULL
70.4	NULL
39.4	NULL
27	NULL
Control	NULL
32.0	NULL
65.5	NULL
33.4	NULL
28	NULL
Control	NULL
ND	NULL
73.8	NULL
37.6	NULL
29	NULL
Control	NULL
ND	NULL
54.0	NULL
33.8	NULL
The	NULL
percentages	NULL
of	NULL
positive	NULL
cells	NULL
for	NULL
each	NULL
antigen	NULL
are	NULL
shown	NULL
.	NULL

Abbreviations	NULL
:	NULL
CD4*	NULL
,	NULL
Leu-8*	NULL
,	NULL
percentages	NULL
of	NULL
cells	NULL
positive	NULL
for	NULL
respective	NULL
antigen	NULL
among	NULL
lymphocytes	NULL
;	NULL
Leu-8*/CD4*	NULL
,	NULL
percentage	NULL
of	NULL
Leu-8-positive	NULL
cells	NULL
among	NULL
CD4*	NULL
cells	NULL
;	NULL
acute	NULL
,	NULL
acute-type	NULL
ATL	NULL
;	NULL
chronic	NULL
,	NULL
chronic-type	NULL
ATL	NULL
;	NULL
control	NULL
,	NULL
control	NULL
samples	NULL
collected	NULL
from	NULL
normal	NULL
volunteers	NULL
;	NULL
ND	NULL
,	NULL
not	NULL
determined	NULL
.	NULL

®	NULL
MFI	NULL
of	NULL
positive	NULL
cells	NULL
was	NULL
lower	NULL
than	NULL
that	NULL
of	NULL
control	NULL
cells	NULL
.	NULL

using	NULL
an	NULL
sL-selectin	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
ELISA	NULL
)	NULL
kit	NULL
(	NULL
Bender	NULL
MedSystems	NULL
,	NULL
Vienna	NULL
,	NULL
Austria	NULL
)	NULL
and	NULL
those	NULL
of	NULL
the	NULL
soluble	NULL
form	NULL
of	NULL
IL-2Ra	NULL
(	NULL
sIL-2Ra	NULL
)	NULL
were	NULL
quantified	NULL
with	NULL
an	NULL
sIL-2Ra	NULL
ELISA	NULL
kit	NULL
(	NULL
T	NULL
cell	NULL
Diagnostics	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

The	NULL
plasma	NULL
or	NULL
serum	NULL
samples	NULL
numbered	NULL
29	NULL
from	NULL
ATL	NULL
patients	NULL
,	NULL
10	NULL
from	NULL
asymptomatic	NULL
carriers	NULL
,	NULL
and	NULL
10	NULL
from	NULL
seronega-tive	NULL
control	NULL
individuals	NULL
.	NULL

Among	NULL
the	NULL
samples	NULL
from	NULL
ATL	NULL
patients	NULL
,	NULL
PBMCs	NULL
from	NULL
5	NULL
were	NULL
included	NULL
in	NULL
the	NULL
analysis	NULL
of	NULL
L-selectin	NULL
mRNA	NULL
expression	NULL
using	NULL
Nothern	NULL
hybridization	NULL
.	NULL

RESULTS	NULL
The	NULL
surface	NULL
expression	NULL
of	NULL
L-selectin	NULL
on	NULL
ATL	NULL
cells	NULL
.	NULL

-	NULL
Flow	NULL
cytometry	NULL
showed	NULL
that	NULL
the	NULL
percentage	NULL
of	NULL
L-selectin-positive	NULL
cells	NULL
among	NULL
those	NULL
that	NULL
were	NULL
CD4*	NULL
was	NULL
65.7	NULL
%	NULL
+	NULL
17.6	NULL
%	NULL
(	NULL
mean	NULL
+	NULL
SD	NULL
)	NULL
in	NULL
ATL	NULL
patients	NULL
,	NULL
whereas	NULL
that	NULL
of	NULL
the	NULL
normal	NULL
control	NULL
was	NULL
36.5	NULL
%	NULL
+	NULL
6.15	NULL
%	NULL
(	NULL
mean	NULL
+	NULL
SD	NULL
;	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
the	NULL
flow	NULL
cytometry	NULL
are	NULL
summarized	NULL
in	NULL
Fig	NULL
1	NULL
.	NULL

The	NULL
population	NULL
of	NULL
Leu-8-positive	NULL
cells	NULL
among	NULL
the	NULL
CD4*	NULL
cells	NULL
that	NULL
almost	NULL
represents	NULL
the	NULL
entire	NULL
leukemic	NULL
cell	NULL
population	NULL
was	NULL
significantly	NULL
high	NULL
in	NULL
ATL	NULL
patients	NULL
(	NULL
P	NULL
=	NULL
.0002	NULL
by	NULL
Mann-Whitney	NULL
U	NULL
test	NULL
)	NULL
.	NULL

L-selectin	NULL
mRNA	NULL
expression	NULL
in	NULL
ATL	NULL
cells	NULL
.	NULL

_	NULL
Northern	NULL
blot	NULL
3111	NULL
100	NULL
%	NULL
f	NULL
|	NULL
80	NULL
60	NULL
.	NULL

40	NULL
.	NULL

Ratio	NULL
of	NULL
Leu8-positive	NULL
cells	NULL
_	NULL
f	NULL
ATL	NULL
-	NULL
Control	NULL
Fig	NULL
1	NULL
.	NULL

The	NULL
ratio	NULL
of	NULL
Leu8g-positive	NULL
cells	NULL
among	NULL
CD4*	NULL
cells	NULL
in	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
ATL	NULL
patients	NULL
and	NULL
normal	NULL
controls	NULL
.	NULL

The	NULL
percentages	NULL
in	NULL
ATL	NULL
patients	NULL
are	NULL
significantly	NULL
higher	NULL
than	NULL
those	NULL
of	NULL
normal	NULL
controls	NULL
(	NULL
Mann-Whitney	NULL
U	NULL
test	NULL
)	NULL
.	NULL

*P	NULL
=	NULL
.0002	NULL
.	NULL

20	NULL
ting	NULL
showed	NULL
that	NULL
normal	NULL
PBMCs	NULL
expressed	NULL
L-selectin	NULL
transcripts	NULL
at	NULL
a	NULL
relatively	NULL
high	NULL
level	NULL
and	NULL
that	NULL
the	NULL
PBMCs	NULL
of	NULL
ATL	NULL
patients	NULL
,	NULL
which	NULL
consisted	NULL
of	NULL
mainly	NULL
ATL	NULL
cells	NULL
,	NULL
expressed	NULL
it	NULL
at	NULL
much	NULL
higher	NULL
levels	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

These	NULL
results	NULL
were	NULL
confirmed	NULL
in	NULL
all	NULL
8	NULL
patients	NULL
with	NULL
ATL	NULL
that	NULL
were	NULL
studied	NULL
.	NULL

We	NULL
then	NULL
tested	NULL
the	NULL
modulation	NULL
of	NULL
gene	NULL
expression	NULL
of	NULL
L-selectin	NULL
by	NULL
activating	NULL
the	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

The	NULL
level	NULL
of	NULL
L-selectin	NULL
expression	NULL
in	NULL
the	NULL
ATL	NULL
cells	NULL
was	NULL
upregulated	NULL
after	NULL
18	NULL
to	NULL
24	NULL
hours	NULL
of	NULL
stimulation	NULL
with	NULL
PMA	NULL
,	NULL
whereas	NULL
the	NULL
normal	NULL
PBMCs	NULL
were	NULL
downregulated	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

All	NULL
of	NULL
the	NULL
three	NULL
HTLV-1	NULL
viral	NULL
transcripts	NULL
,	NULL
ie	NULL
,	NULL
geno-mic	NULL
,	NULL
env	NULL
,	NULL
and	NULL
pX	NULL
,	NULL
were	NULL
detected	NULL
after	NULL
stimulation	NULL
,	NULL
whereas	NULL
they	NULL
were	NULL
not	NULL
expressed	NULL
in	NULL
fresh	NULL
leukemic	NULL
cells	NULL
at	NULL
a	NULL
detectable	NULL
level	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
fresh	NULL
primary	NULL
ATL	NULL
cells	NULL
constitu-	NULL
L-selectin	NULL
ribosomal	NULL
RNA	NULL
Fig	NULL
2	NULL
.	NULL

Expression	NULL
of	NULL
L-selectin	NULL
mRNA	NULL
in	NULL
fresh	NULL
PBMCs	NULL
of	NULL
ATL	NULL
patients	NULL
.	NULL

Ten	NULL
micrograms	NULL
of	NULL
total	NULL
RNA	NULL
sample	NULL
was	NULL
applied	NULL
to	NULL
each	NULL
lane	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
normal	NULL
fresh	NULL
PBMC	NULL
RNA	NULL
;	NULL
lanes	NULL
2	NULL
through	NULL
4	NULL
,	NULL
PBMC	NULL
RNA	NULL
samples	NULL
from	NULL
patients	NULL
with	NULL
acute	NULL
ATL	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3112	NULL
1	NULL
2	NULL
3	NULL
4	NULL
L-selectin	NULL
-	NULL
<	NULL
18S	NULL
HTLV-1	NULL
RNA	NULL
Fig	NULL
3	NULL
.	NULL

Aberrant	NULL
regulation	NULL
of	NULL
L-selectin	NULL
mRNA	NULL
expression	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
HTLV-1	NULL
viral	NULL
mRNA	NULL
by	NULL
PMA	NULL
stimulation	NULL
.	NULL

Lanes	NULL
1	NULL
and	NULL
2	NULL
,	NULL
fresh	NULL
(	NULL
1	NULL
)	NULL
and	NULL
PMA-stimulated	NULL
(	NULL
2	NULL
)	NULL
PBMC	NULL
samples	NULL
from	NULL
a	NULL
normal	NULL
con-trol	NULL
;	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
,	NULL
fresh	NULL
(	NULL
3	NULL
)	NULL
and	NULL
PMA-stimulated	NULL
(	NULL
4	NULL
)	NULL
PBMC	NULL
samples	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
acute	NULL
ATL	NULL
.	NULL

L-selectin	NULL
mRNA	NULL
expression	NULL
was	NULL
upregulated	NULL
after	NULL
PMA	NULL
stimulation	NULL
in	NULL
ATL	NULL
cells	NULL
.	NULL

HTLV-1	NULL
viral	NULL
mRNA	NULL
was	NULL
also	NULL
induced	NULL
by	NULL
PMA	NULL
stimulation	NULL
of	NULL
ATL	NULL
cells	NULL
.	NULL

tively	NULL
overexpressed	NULL
L-selectin	NULL
mRNA	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
viral	NULL
gene	NULL
expression	NULL
,	NULL
which	NULL
was	NULL
further	NULL
upregulated	NULL
after	NULL
PMA	NULL
stimulation	NULL
.	NULL

The	NULL
correlation	NULL
between	NULL
viral	NULL
gene	NULL
expression	NULL
including	NULL
pX	NULL
mRNA	NULL
and	NULL
upregulation	NULL
of	NULL
L-selectin	NULL
gene	NULL
expression	NULL
suggested	NULL
that	NULL
the	NULL
viral	NULL
transactivator	NULL
,	NULL
Tax	NULL
that	NULL
is	NULL
encoded	NULL
by	NULL
pX	NULL
mRNA	NULL
,	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
L-selectin	NULL
gene	NULL
expression	NULL
,	NULL
as	NULL
it	NULL
is	NULL
with	NULL
other	NULL
cellular	NULL
genes	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
L-selectin	NULL
mRNA	NULL
in	NULL
the	NULL
infiltrating	NULL
leukemic	NULL
cells	NULL
was	NULL
studied	NULL
using	NULL
in	NULL
situ	NULL
hybridization	NULL
of	NULL
the	NULL
liver	NULL
samples	NULL
of	NULL
two	NULL
ATL	NULL
patients	NULL
that	NULL
show	NULL
perivascular	NULL
infiltration	NULL
of	NULL
ATL	NULL
cells	NULL
.	NULL

A	NULL
liver	NULL
biopsy	NULL
specimen	NULL
of	NULL
a	NULL
chronic	NULL
hepatitis	NULL
patient	NULL
served	NULL
as	NULL
a	NULL
control	NULL
.	NULL

Serial	NULL
sections	NULL
of	NULL
the	NULL
liver	NULL
were	NULL
hybridized	NULL
with	NULL
DIG-labeled	NULL
antisense	NULL
(	NULL
Fig	NULL
4A	NULL
)	NULL
or	NULL
sense	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
L-selectin	NULL
cRNA	NULL
probe	NULL
.	NULL

Hybridization	NULL
signals	NULL
for	NULL
L-selectin	NULL
mRNA	NULL
were	NULL
detected	NULL
in	NULL
infiltrating	NULL
mononuclear	NULL
cells	NULL
in	NULL
Glisson	NULL
's	NULL
sheath	NULL
of	NULL
the	NULL
liver	NULL
(	NULL
Fig	NULL
4A	NULL
)	NULL
only	NULL
when	NULL
the	NULL
antisense	NULL
cRNA	NULL
probe	NULL
was	NULL
used	NULL
.	NULL

Immunohistochemical	NULL
staining	NULL
with	NULL
UCHL-1	NULL
monoclonal	NULL
antibody	NULL
showed	NULL
that	NULL
most	NULL
of	NULL
the	NULL
infiltrating	NULL
cells	NULL
were	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
4C	NULL
)	NULL
.	NULL

Almost	NULL
no	NULL
hybridization	NULL
for	NULL
L-selectin	NULL
mRNA	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
infiltrating	NULL
lymphocytes	NULL
in	NULL
the	NULL
biopsy	NULL
specimen	NULL
of	NULL
a	NULL
chronic	NULL
active	NULL
hepatitis	NULL
patient	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Organ	NULL
infiltration	NULL
of	NULL
a	NULL
rat	NULL
T-cell	NULL
line	NULL
that	NULL
overexpresses	NULL
L-selectin	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
5	NULL
,	NULL
many	NULL
FITC-labeled	NULL
cells	NULL
were	NULL
detected	NULL
immunohistochemically	NULL
in	NULL
Glisson	NULL
's	NULL
sheath	NULL
of	NULL
the	NULL
liver	NULL
when	NULL
TARL-2	NULL
(	NULL
L+	NULL
)	NULL
cells	NULL
were	NULL
injected	NULL
,	NULL
whereas	NULL
only	NULL
a	NULL
few	NULL
were	NULL
detected	NULL
when	NULL
the	NULL
original	NULL
cells	NULL
were	NULL
used	NULL
.	NULL

Effcient	NULL
FITC	NULL
labeling	NULL
of	NULL
both	NULL
cells	NULL
was	NULL
confirmed	NULL
by	NULL
detection	NULL
of	NULL
the	NULL
injected	NULL
cells	NULL
in	NULL
the	NULL
lung	NULL
in	NULL
which	NULL
these	NULL
two	NULL
cells	NULL
did	NULL
not	NULL
show	NULL
a	NULL
marked	NULL
difference	NULL
in	NULL
the	NULL
number	NULL
of	NULL
trapped	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

TATEWAKI	NULL
ET	NULL
AL	NULL
The	NULL
induction	NULL
of	NULL
L-selectin	NULL
gene	NULL
expression	NULL
by	NULL
Tax	NULL
in	NULL
JPX-9	NULL
cells	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
effect	NULL
of	NULL
Tax	NULL
on	NULL
the	NULL
L-selectin	NULL
gene	NULL
expression	NULL
,	NULL
we	NULL
used	NULL
JPX-9	NULL
cells	NULL
that	NULL
have	NULL
an	NULL
inducible	NULL
Tax	NULL
gene	NULL
.	NULL

We	NULL
studied	NULL
the	NULL
time	NULL
course	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
L-selectin	NULL
and	NULL
Tax	NULL
by	NULL
means	NULL
of	NULL
Northern	NULL
blotting	NULL
.	NULL

CdCl	NULL
;	NULL
added	NULL
to	NULL
the	NULL
culture	NULL
medium	NULL
induced	NULL
Tax	NULL
gene	NULL
expression	NULL
in	NULL
JPX-9	NULL
cells	NULL
within	NULL
1.5	NULL
hours	NULL
.	NULL
``	NULL

''	NULL
Although	NULL
L-selectin	NULL
gene	NULL
is	NULL
constitutively	NULL
expressed	NULL
in	NULL
JPX-9	NULL
cells	NULL
at	NULL
a	NULL
relatively	NULL
high	NULL
level	NULL
,	NULL
the	NULL
expression	NULL
started	NULL
to	NULL
increase	NULL
along	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
Tax	NULL
expression	NULL
.	NULL

It	NULL
showed	NULL
a	NULL
small	NULL
peak	NULL
at	NULL
2	NULL
hours	NULL
,	NULL
a	NULL
small	NULL
decrease	NULL
at	NULL
6	NULL
hours	NULL
,	NULL
and	NULL
then	NULL
a	NULL
continuous	NULL
increase	NULL
until	NULL
33	NULL
hours	NULL
,	NULL
reaching	NULL
about	NULL
double	NULL
the	NULL
basal	NULL
level	NULL
(	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

CdCl	NULL
;	NULL
did	NULL
not	NULL
influence	NULL
the	NULL
level	NULL
of	NULL
L-selectin	NULL
gene	NULL
expression	NULL
in	NULL
the	NULL
parental	NULL
Jurkat	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
results	NULL
suggested	NULL
that	NULL
Tax	NULL
increased	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
L-selectin	NULL
gene	NULL
and	NULL
that	NULL
endogenous	NULL
cellular	NULL
factors	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
.	NULL

The	NULL
L-selectin	NULL
promoter	NULL
is	NULL
transactivated	NULL
by	NULL
HTLV-1	NULL
Tax	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
the	NULL
L-selectin	NULL
promoter	NULL
,	NULL
which	NULL
we	NULL
identified	NULL
(	NULL
Tatewaki	NULL
et	NULL
al	NULL
,	NULL
submitted	NULL
for	NULL
publication	NULL
)	NULL
,	NULL
responds	NULL
to	NULL
Tax	NULL
,	NULL
we	NULL
assayed	NULL
CAT	NULL
by	NULL
means	NULL
of	NULL
transient	NULL
cotransfection	NULL
with	NULL
the	NULL
Tax	NULL
expression	NULL
vector	NULL
.	NULL

The	NULL
reporter	NULL
plasmid	NULL
,	NULL
pLS-1	NULL
CAT	NULL
,	NULL
has	NULL
the	NULL
L-selectin	NULL
promoter	NULL
fragment	NULL
up	NULL
to	NULL
-885	NULL
.	NULL

The	NULL
promoter	NULL
was	NULL
activated	NULL
by	NULL
Tax	NULL
both	NULL
in	NULL
Jurkat	NULL
and	NULL
FL	NULL
cell	NULL
lines	NULL
.	NULL

Representative	NULL
results	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
7	NULL
.	NULL

The	NULL
magnitude	NULL
of	NULL
transactivation	NULL
by	NULL
Tax	NULL
was	NULL
about	NULL
fivefold	NULL
in	NULL
FL	NULL
cells	NULL
and	NULL
a	NULL
little	NULL
less	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
Tax-responsive	NULL
element	NULL
(	NULL
s	NULL
)	NULL
,	NULL
we	NULL
prepared	NULL
CAT	NULL
reporter	NULL
plasmids	NULL
with	NULL
a	NULL
serially	NULL
deleted	NULL
promoter	NULL
sequence	NULL
and	NULL
tested	NULL
the	NULL
response	NULL
to	NULL
Tax	NULL
.	NULL

However	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
transactivation	NULL
were	NULL
gradually	NULL
decreased	NULL
with	NULL
deletion	NULL
and	NULL
no	NULL
specific	NULL
region	NULL
that	NULL
affected	NULL
the	NULL
response	NULL
was	NULL
identified	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggested	NULL
that	NULL
multiple	NULL
elements	NULL
in	NULL
the	NULL
promoter	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
transactivation	NULL
by	NULL
Tax	NULL
.	NULL

Elevated	NULL
serum	NULL
levels	NULL
of	NULL
sL-selectin	NULL
in	NULL
ATL	NULL
patients	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
overexpression	NULL
of	NULL
L-selectin	NULL
by	NULL
ATL	NULL
cells	NULL
in	NULL
vivo	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
level	NULL
of	NULL
sL-selectin	NULL
in	NULL
the	NULL
sera	NULL
of	NULL
29	NULL
ATL	NULL
patients	NULL
,	NULL
10	NULL
asymptomatic	NULL
carriers	NULL
,	NULL
and	NULL
10	NULL
normal	NULL
blood	NULL
donors	NULL
.	NULL

We	NULL
also	NULL
measured	NULL
the	NULL
serum	NULL
level	NULL
of	NULL
IL-2Ra	NULL
,	NULL
which	NULL
is	NULL
a	NULL
good	NULL
marker	NULL
of	NULL
leukemic	NULL
cell	NULL
mass	NULL
in	NULL
vivo	NULL
.	NULL
``	NULL

The	NULL
mean	NULL
level	NULL
of	NULL
sL-selectin	NULL
in	NULL
29	NULL
patients	NULL
with	NULL
ATL	NULL
was	NULL
significantly	NULL
increased	NULL
(	NULL
mean	NULL
+	NULL
SD	NULL
,	NULL
4,215.4	NULL
+	NULL
4,111	NULL
ng/	NULL
mL	NULL
)	NULL
compared	NULL
with	NULL
those	NULL
in	NULL
asymptomatic	NULL
carriers	NULL
and	NULL
normal	NULL
blood	NULL
donors	NULL
(	NULL
mean	NULL
+	NULL
SD	NULL
,	NULL
1,148.0	NULL
+	NULL
269	NULL
ng/mL	NULL
and	NULL
991.9	NULL
+	NULL
224	NULL
ng/mL	NULL
,	NULL
respectively	NULL
;	NULL
Fig	NULL
8	NULL
)	NULL
.	NULL

We	NULL
studied	NULL
the	NULL
correlation	NULL
between	NULL
sL-selectin	NULL
and	NULL
sIL-2Ra	NULL
in	NULL
samples	NULL
from	NULL
25	NULL
patients	NULL
with	NULL
ATL	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
9	NULL
,	NULL
the	NULL
level	NULL
of	NULL
sL-selectin	NULL
correlated	NULL
well	NULL
with	NULL
that	NULL
of	NULL
sIL-2Ra	NULL
(	NULL
y	NULL
=	NULL
0.6	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
serum	NULL
level	NULL
of	NULL
sL-selectin	NULL
depends	NULL
on	NULL
the	NULL
leukemic	NULL
cell	NULL
mass	NULL
.	NULL

These	NULL
results	NULL
provided	NULL
more	NULL
evidence	NULL
that	NULL
L-selectin	NULL
is	NULL
overexpressed	NULL
by	NULL
ATL	NULL
cells	NULL
in	NULL
vivo	NULL
.	NULL

DISCUSSION	NULL
The	NULL
adhesion	NULL
properties	NULL
of	NULL
peripheral	NULL
blood	NULL
leukemic	NULL
cells	NULL
from	NULL
10	NULL
patients	NULL
with	NULL
ATL	NULL
have	NULL
been	NULL
characterized	NULL
by	NULL
Ishikawa	NULL
et	NULL
al	NULL
.	NULL
``	NULL

They	NULL
showed	NULL
that	NULL
E-selectin	NULL
and	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
VCAM-1	NULL
)	NULL
mediate	NULL
ATL	NULL
cell	NULL
adhesion	NULL
to	NULL
endothelial	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
the	NULL
counter-receptors	NULL
on	NULL
ATL	NULL
cells	NULL
for	NULL
E-selectin	NULL
and	NULL
VCAM-1	NULL
remained	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

OVEREXPRESSION	NULL
OF	NULL
L-SELECTIN	NULL
IN	NULL
ATL	NULL
Adhesion	NULL
molcules	NULL
expressed	NULL
on	NULL
ATL	NULL
cells	NULL
have	NULL
not	NULL
been	NULL
well	NULL
characterized	NULL
.	NULL

Fukudome	NULL
et	NULL
al	NULL
``	NULL
``	NULL
reported	NULL
that	NULL
intercellu-lar	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
ICAM-1	NULL
)	NULL
expression	NULL
was	NULL
highly	NULL
induced	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
transformed	NULL
by	NULL
HTLV-1	NULL
and	NULL
fresh	NULL
ATL	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
not	NULL
known	NULL
whether	NULL
they	NULL
are	NULL
involved	NULL
in	NULL
organ	NULL
infiltration	NULL
of	NULL
ATL	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
further	NULL
characterization	NULL
of	NULL
adhesion	NULL
molecules	NULL
expressed	NULL
on	NULL
ATL	NULL
cells	NULL
should	NULL
help	NULL
understand	NULL
the	NULL
mechanism	NULL
underlying	NULL
organ	NULL
in-filtration	NULL
.	NULL

Fig	NULL
5	NULL
.	NULL

-	NULL
Infiltration	NULL
in	NULL
the	NULL
liver	NULL
by	NULL
an	NULL
L-selectin	NULL
overexpressing	NULL
T-cell	NULL
line	NULL
,	NULL
TARL-2	NULL
L	NULL
(	NULL
+	NULL
)	NULL
,	NULL
after	NULL
intravenous	NULL
injection	NULL
.	NULL

The	NULL
liver	NULL
from	NULL
a	NULL
rat	NULL
injected	NULL
with	NULL
TARL-2	NULL
L	NULL
(	NULL
+	NULL
)	NULL
is	NULL
indicated	NULL
as	NULL
L	NULL
(	NULL
+	NULL
)	NULL
and	NULL
that	NULL
injected	NULL
with	NULL
the	NULL
original	NULL
TARL-2	NULL
as	NULL
L	NULL
(	NULL
-	NULL
)	NULL
(	NULL
lower	NULL
left	NULL
)	NULL
.	NULL

A	NULL
control	NULL
reaction	NULL
without	NULL
anti-FITC	NULL
antibody	NULL
using	NULL
the	NULL
liver	NULL
of	NULL
a	NULL
rat	NULL
injected	NULL
with	NULL
TARL-2	NULL
L	NULL
(	NULL
+	NULL
)	NULL
is	NULL
indicated	NULL
as	NULL
PBS	NULL
(	NULL
upper	NULL
left	NULL
)	NULL
.	NULL

3113	NULL
Fig	NULL
4	NULL
.	NULL

Expression	NULL
of	NULL
L-selectin	NULL
mRNA	NULL
in	NULL
the	NULL
infitrating	NULL
ATL	NULL
cells	NULL
in	NULL
the	NULL
liver	NULL
.	NULL

(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
Hybridization	NULL
with	NULL
antisense	NULL
and	NULL
sense	NULL
probes	NULL
for	NULL
L-selectin	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Immunohistochemical	NULL
detection	NULL
of	NULL
T	NULL
cells	NULL
using	NULL
UCHL-1	NULL
monoclonal	NULL
antibody	NULL
.	NULL

We	NULL
showed	NULL
that	NULL
the	NULL
L-selectin	NULL
gene	NULL
is	NULL
constitutively	NULL
overexpressed	NULL
in	NULL
ATL	NULL
cells	NULL
and	NULL
that	NULL
the	NULL
viral	NULL
transactivator	NULL
Tax	NULL
can	NULL
induce	NULL
its	NULL
expression	NULL
.	NULL

We	NULL
also	NULL
showed	NULL
that	NULL
the	NULL
serum	NULL
levels	NULL
of	NULL
sL-selectin	NULL
in	NULL
ATL	NULL
patients	NULL
were	NULL
significantly	NULL
elevated	NULL
and	NULL
that	NULL
they	NULL
correlated	NULL
well	NULL
with	NULL
those	NULL
of	NULL
sIL-2Ra	NULL
«	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
constitutive	NULL
overexpression	NULL
of	NULL
L-selectin	NULL
is	NULL
one	NULL
of	NULL
the	NULL
characteristic	NULL
phenotypes	NULL
of	NULL
ATL	NULL
cells	NULL
.	NULL

Our	NULL
flow	NULL
cytometric	NULL
study	NULL
of	NULL
surface	NULL
markers	NULL
of	NULL
ATL	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3114	NULL
A	NULL
time	NULL
(	NULL
h	NULL
)	NULL
0	NULL
2	NULL
4	NULL
11	NULL
18	NULL
33	NULL
L-Selectin	NULL
HTLV-1	NULL
Tax	NULL
GAPDH	NULL
Fig	NULL
6	NULL
.	NULL

TATEWAKI	NULL
ET	NULL
AL	NULL
xe	NULL
}	NULL
o	NULL
(	NULL
«	NULL
]	NULL
100	NULL
relative	NULL
radioactivity	NULL
(	NULL
%	NULL
)	NULL
U	NULL
O	NULL
0	NULL
2	NULL
4	NULL
11	NULL
18	NULL
33	NULL
time	NULL
(	NULL
h	NULL
)	NULL
Induction	NULL
of	NULL
L-selectin	NULL
mRNA	NULL
expression	NULL
after	NULL
the	NULL
expression	NULL
of	NULL
HTLV-1	NULL
Tax	NULL
in	NULL
JPX9	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Results	NULL
of	NULL
Northern	NULL
blot	NULL
hybridization	NULL
.	NULL

Samples	NULL
of	NULL
10	NULL
pg	NULL
total	NULL
RNA	NULL
were	NULL
subjected	NULL
for	NULL
formalin-agarose	NULL
gel	NULL
electrophoresis	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
relative	NULL
intensities	NULL
of	NULL
the	NULL
hybridization	NULL
signals	NULL
.	NULL

Measured	NULL
radioactivity	NULL
was	NULL
corrected	NULL
using	NULL
that	NULL
of	NULL
GAPDH	NULL
.	NULL

cells	NULL
cleary	NULL
showed	NULL
that	NULL
they	NULL
expressed	NULL
Leu-8	NULL
antigen	NULL
(	NULL
Table	NULL
1	NULL
and	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

The	NULL
mean	NULL
fluorescence	NULL
intensity	NULL
(	NULL
MFI	NULL
)	NULL
of	NULL
positive	NULL
cells	NULL
was	NULL
generally	NULL
low	NULL
in	NULL
ATL	NULL
cells	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
normal	NULL
controls	NULL
.	NULL

Considering	NULL
the	NULL
constitutive	NULL
overexpression	NULL
of	NULL
mRNA	NULL
shown	NULL
in	NULL
this	NULL
study	NULL
,	NULL
low	NULL
MFI	NULL
may	NULL
suggest	NULL
a	NULL
rapid	NULL
turnover	NULL
of	NULL
the	NULL
protein	NULL
.	NULL

In	NULL
line	NULL
with	NULL
this	NULL
notion	NULL
,	NULL
other	NULL
investigators	NULL
have	NULL
reported	NULL
variable	NULL
levels	NULL
of	NULL
L-selectin	NULL
expression	NULL
on	NULL
ATL	NULL
cells	NULL
.	NULL
``	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
L-selectin	NULL
surface	NULL
expression	NULL
is	NULL
downregulated	NULL
by	NULL
various	NULL
leukocyte	NULL
isolation	NULL
procedures	NULL
,	NULL
``	NULL
``	NULL
which	NULL
may	NULL
explain	NULL
some	NULL
inconsistency	NULL
in	NULL
the	NULL
data	NULL
reported	NULL
by	NULL
different	NULL
groups	NULL
.	NULL

Therefore	NULL
,	NULL
to	NULL
characterize	NULL
the	NULL
L-selectin	NULL
expression	NULL
,	NULL
mRNA	NULL
expression	NULL
should	NULL
be	NULL
studied	NULL
by	NULL
such	NULL
means	NULL
as	NULL
Northern	NULL
blotting	NULL
in	NULL
addition	NULL
to	NULL
flow	NULL
cytometry	NULL
and	NULL
immunocytochem-istry	NULL
.	NULL

The	NULL
results	NULL
of	NULL
our	NULL
Northern	NULL
blot	NULL
analysis	NULL
showed	NULL
a	NULL
rather	NULL
constant	NULL
and	NULL
high	NULL
level	NULL
of	NULL
mRNA	NULL
expression	NULL
in	NULL
ATL	NULL
samples	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
results	NULL
of	NULL
our	NULL
flow	NULL
cytometric	NULL
analysis	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
demonstration	NULL
of	NULL
L-selectin	NULL
mRNA	NULL
in	NULL
the	NULL
infiltrating	NULL
cells	NULL
in	NULL
the	NULL
liver	NULL
of	NULL
ATL	NULL
A	NULL
B	NULL
%	NULL
Conversion	NULL
Tax	NULL
patients	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
,	NULL
but	NULL
not	NULL
in	NULL
the	NULL
liver	NULL
with	NULL
inflammatory	NULL
infiltration	NULL
of	NULL
lymphocytes	NULL
,	NULL
appears	NULL
to	NULL
provide	NULL
more	NULL
evidence	NULL
for	NULL
abnormal	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
,	NULL
because	NULL
it	NULL
was	NULL
reported	NULL
that	NULL
L-selectin	NULL
expression	NULL
was	NULL
downregulated	NULL
after	NULL
extravasation	NULL
.	NULL
``	NULL

Subsets	NULL
of	NULL
CD4*	NULL
T	NULL
cells	NULL
that	NULL
showed	NULL
enhanced	NULL
transendo-thelial	NULL
migration	NULL
were	NULL
identified	NULL
as	NULL
CD29	NULL
``	NULL
``	NULL
®	NULL
``	NULL
,	NULL
and	NULL
CD45RA~	NULL
.	NULL

``	NULL
°	NULL
These	NULL
phenotypes	NULL
are	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
ATL	NULL
cells	NULL
.	NULL
``	NULL

'	NULL
In	NULL
addition	NULL
to	NULL
this	NULL
,	NULL
the	NULL
overexpression	NULL
of	NULL
L-selectin	NULL
may	NULL
render	NULL
ATL	NULL
cells	NULL
more	NULL
sticky	NULL
to	NULL
vascular	NULL
endothelial	NULL
cells	NULL
than	NULL
normal	NULL
T	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
ATL	NULL
and	NULL
HTLV-1-infected	NULL
cells	NULL
produce	NULL
various	NULL
inflammatory	NULL
cyto-kines	NULL
.	NULL
``	NULL

These	NULL
phenotypic	NULL
characteristics	NULL
of	NULL
ATL	NULL
cells	NULL
would	NULL
enable	NULL
them	NULL
to	NULL
activate	NULL
vascular	NULL
endothelial	NULL
cells	NULL
to	NULL
express	NULL
adhesion	NULL
molecules	NULL
and	NULL
to	NULL
attach	NULL
themselves	NULL
firmly	NULL
to	NULL
activated	NULL
endothelium	NULL
.	NULL

The	NULL
notion	NULL
that	NULL
overexpression	NULL
of	NULL
L-selectin	NULL
itself	NULL
can	NULL
affect	NULL
the	NULL
lymphocyte	NULL
recirculation	NULL
seems	NULL
to	NULL
be	NULL
partly	NULL
supported	NULL
by	NULL
our	NULL
observation	NULL
that	NULL
a	NULL
rat	NULL
T-cell	NULL
line	NULL
that	NULL
overexpresses	NULL
L-selectin	NULL
showed	NULL
an	NULL
increased	NULL
Fig	NULL
7	NULL
.	NULL

Transactivation	NULL
of	NULL
the	NULL
L-selectin	NULL
gene	NULL
promoter	NULL
by	NULL
HTLV-1	NULL
Tax	NULL
.	NULL

Representative	NULL
results	NULL
of	NULL
a	NULL
CAT	NULL
assay	NULL
after	NULL
the	NULL
cotransfection	NULL
of	NULL
pLS-1	NULL
CAT	NULL
and	NULL
a	NULL
Tax	NULL
expression	NULL
vector	NULL
in	NULL
FL	NULL
cells	NULL
(	NULL
A	NULL
)	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
conversion	NULL
of	NULL
chloramphenicol	NULL
that	NULL
is	NULL
corrected	NULL
by	NULL
the	NULL
3-Gal	NULL
activity	NULL
is	NULL
shown	NULL
in	NULL
(	NULL
B	NULL
)	NULL
.	NULL

The	NULL
CAT	NULL
activity	NULL
was	NULL
transactivated	NULL
about	NULL
fivefold	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Tax	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

OVEREXPRESSION	NULL
OF	NULL
L-SELECTIN	NULL
IN	NULL
ATL	NULL
10000	NULL
GOOG	NULL
Gbo0	NULL
0	NULL
©	NULL
©6000	NULL
CoP	NULL
06	NULL
1000	NULL
s-L-Selectin	NULL
(	NULL
ng	NULL
/	NULL
ml	NULL
)	NULL
100	NULL
ATL	NULL
_	NULL
AC	NULL
Cont	NULL
.	NULL

Fig	NULL
8	NULL
.	NULL

-	NULL
Elevated	NULL
serum	NULL
levels	NULL
of	NULL
sL-selectin	NULL
in	NULL
ATL	NULL
patients	NULL
.	NULL

Plasma	NULL
levels	NULL
of	NULL
sL-selectin	NULL
in	NULL
29	NULL
ATL	NULL
patients	NULL
,	NULL
10	NULL
asymptomatic	NULL
carriers	NULL
{	NULL
(	NULL
AC	NULL
)	NULL
,	NULL
and	NULL
10	NULL
normal	NULL
blood	NULL
donors	NULL
(	NULL
Cont	NULL
.	NULL
)	NULL

were	NULL
plotted	NULL
.	NULL

Bars	NULL
indicate	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
.	NULL

*P	NULL
<	NULL
.05	NULL
using	NULL
the	NULL
Student	NULL
's	NULL
test	NULL
.	NULL

level	NULL
of	NULL
organ	NULL
infiltration	NULL
when	NULL
injected	NULL
into	NULL
a	NULL
rat	NULL
intravenously	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
.	NULL

However	NULL
,	NULL
Schleiffenbaum	NULL
et	NULL
al	NULL
``	NULL
``	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
increased	NULL
levels	NULL
of	NULL
sL-selectin	NULL
in	NULL
the	NULL
medium	NULL
inhibited	NULL
the	NULL
interaction	NULL
between	NULL
L-selectin	NULL
and	NULL
its	NULL
ligands	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
appears	NULL
more	NULL
likely	NULL
that	NULL
,	NULL
even	NULL
though	NULL
ATL	NULL
cells	NULL
might	NULL
have	NULL
enhanced	NULL
capacity	NULL
to	NULL
adhere	NULL
to	NULL
and	NULL
transmigrate	NULL
the	NULL
endothelial	NULL
cells	NULL
,	NULL
organ	NULL
infiltration	NULL
is	NULL
determined	NULL
by	NULL
the	NULL
dynamic	NULL
balance	NULL
in	NULL
vivo	NULL
between	NULL
the	NULL
increased	NULL
stickiness	NULL
of	NULL
ATL	NULL
cells	NULL
and	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
sL-selectin	NULL
in	NULL
the	NULL
serum	NULL
.	NULL

Thus	NULL
,	NULL
to	NULL
understand	NULL
the	NULL
biologic	NULL
significance	NULL
of	NULL
the	NULL
L-selectin	NULL
overexpression	NULL
,	NULL
the	NULL
correlation	NULL
between	NULL
the	NULL
serum	NULL
levels	NULL
of	NULL
sL-selectin	NULL
and	NULL
the	NULL
clinical	NULL
manifestation	NULL
of	NULL
organ	NULL
infiltration	NULL
in	NULL
ATL	NULL
patients	NULL
of	NULL
each	NULL
clinical	NULL
subtype	NULL
should	NULL
be	NULL
further	NULL
studied	NULL
,	NULL
and	NULL
the	NULL
gene	NULL
expression	NULL
of	NULL
other	NULL
adhesion	NULL
molecules	NULL
as	NULL
well	NULL
as	NULL
inflammatory	NULL
cytokines	NULL
should	NULL
be	NULL
characterized	NULL
.	NULL

As	NULL
mentioned	NULL
before	NULL
,	NULL
HTLV-1	NULL
Tax	NULL
induces	NULL
expression	NULL
of	NULL
cytokines	NULL
,	NULL
growth	NULL
factors	NULL
,	NULL
and	NULL
their	NULL
receptors	NULL
.	NULL
``	NULL

IL-2Ra	NULL
and	NULL
parathyroid	NULL
hormone-related	NULL
protein	NULL
(	NULL
PTHrP	NULL
)	NULL
are	NULL
examples	NULL
of	NULL
these	NULL
genes	NULL
,	NULL
and	NULL
they	NULL
are	NULL
constitutively	NULL
overexpressed	NULL
in	NULL
ATL	NULL
cells	NULL
.	NULL
``	NULL

The	NULL
overexpression	NULL
of	NULL
cellular	NULL
genes	NULL
that	NULL
can	NULL
be	NULL
transactivated	NULL
by	NULL
Tax	NULL
is	NULL
one	NULL
of	NULL
the	NULL
common	NULL
features	NULL
of	NULL
ATL	NULL
cells	NULL
.	NULL

The	NULL
L-selectin	NULL
gene	NULL
appears	NULL
to	NULL
be	NULL
the	NULL
first	NULL
example	NULL
of	NULL
adhesion	NULL
molecules	NULL
with	NULL
this	NULL
characteristic	NULL
.	NULL

The	NULL
level	NULL
of	NULL
transactivation	NULL
of	NULL
the	NULL
L-selectin	NULL
promoter	NULL
induced	NULL
by	NULL
Tax	NULL
was	NULL
about	NULL
fivefold	NULL
in	NULL
repeated	NULL
experiments	NULL
,	NULL
which	NULL
is	NULL
lower	NULL
than	NULL
that	NULL
of	NULL
reported	NULL
cellular	NULL
genes	NULL
.	NULL

This	NULL
difference	NULL
could	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
relatively	NULL
high	NULL
level	NULL
of	NULL
3115	NULL
background	NULL
activity	NULL
of	NULL
L-selectin	NULL
promoter	NULL
both	NULL
in	NULL
Jurkat	NULL
cells	NULL
and	NULL
FL	NULL
cells	NULL
(	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

Similar	NULL
observations	NULL
were	NULL
recently	NULL
reported	NULL
by	NULL
Ohbo	NULL
et	NULL
al	NULL
``	NULL
``	NULL
on	NULL
the	NULL
IL-2Ry	NULL
chain	NULL
gene	NULL
expression	NULL
that	NULL
was	NULL
transactivated	NULL
by	NULL
HTLV-1	NULL
Tax	NULL
.	NULL

It	NULL
may	NULL
also	NULL
be	NULL
due	NULL
to	NULL
the	NULL
difference	NULL
in	NULL
the	NULL
molecular	NULL
mechanism	NULL
underlying	NULL
the	NULL
transactivation	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
HTLV-1	NULL
Tax	NULL
transactivates	NULL
gene	NULL
expression	NULL
through	NULL
interactions	NULL
with	NULL
cellular	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
CREBP	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
and	NULL
SRF	NULL
.	NULL
``	NULL

No	NULL
consensus	NULL
sequence	NULL
elements	NULL
for	NULL
these	NULL
factors	NULL
were	NULL
found	NULL
in	NULL
the	NULL
L-selectin	NULL
promoter	NULL
up	NULL
to	NULL
-885	NULL
bp	NULL
.	NULL

In-stead	NULL
,	NULL
there	NULL
are	NULL
multiple	NULL
sequence	NULL
elements	NULL
for	NULL
Ets	NULL
family	NULL
oncogenes	NULL
(	NULL
Tatewaki	NULL
et	NULL
al	NULL
,	NULL
submitted	NULL
for	NULL
publication	NULL
)	NULL
,	NULL
which	NULL
reportedly	NULL
participate	NULL
in	NULL
the	NULL
transactivation	NULL
of	NULL
HTLV-1	NULL
LTR	NULL
and	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
PTHrP	NULL
gene	NULL
.	NULL

``	NULL
``	NULL
``	NULL
°	NULL
Functional	NULL
characterization	NULL
is	NULL
now	NULL
under	NULL
way	NULL
to	NULL
answer	NULL
whether	NULL
these	NULL
characteristics	NULL
of	NULL
the	NULL
L-selectin	NULL
promoter	NULL
could	NULL
explain	NULL
the	NULL
apparent	NULL
difference	NULL
in	NULL
the	NULL
response	NULL
to	NULL
Tax	NULL
.	NULL

In	NULL
all	NULL
the	NULL
ATL	NULL
samples	NULL
that	NULL
we	NULL
have	NULL
so	NULL
far	NULL
examined	NULL
,	NULL
viral	NULL
mRNAs	NULL
were	NULL
not	NULL
detected	NULL
using	NULL
Northern	NULL
blotting	NULL
.	NULL

Furthermore	NULL
,	NULL
our	NULL
RT-PCR	NULL
studies	NULL
of	NULL
fresh	NULL
primary	NULL
ATL	NULL
cells	NULL
from	NULL
25	NULL
patients	NULL
could	NULL
not	NULL
detect	NULL
pX	NULL
mRNA	NULL
in	NULL
more	NULL
than	NULL
half	NULL
of	NULL
them	NULL
.	NULL

The	NULL
amplification	NULL
of	NULL
the	NULL
pX	NULL
mRNA	NULL
was	NULL
very	NULL
weak	NULL
in	NULL
the	NULL
remaining	NULL
samples	NULL
and	NULL
it	NULL
corresponded	NULL
to	NULL
a	NULL
level	NULL
of	NULL
1	NULL
viral	NULL
mRNA	NULL
expressing	NULL
cell	NULL
among	NULL
1	NULL
x	NULL
10+	NULL
negative	NULL
cells	NULL
(	NULL
Watanabe	NULL
et	NULL
al	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
could	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
amplified	NULL
pX	NULL
mRNA	NULL
was	NULL
expressed	NULL
in	NULL
nontransformed	NULL
HTLV-1-infected	NULL
cells	NULL
that	NULL
contaminated	NULL
the	NULL
samples	NULL
.	NULL

It	NULL
was	NULL
also	NULL
shown	NULL
that	NULL
nearly	NULL
half	NULL
of	NULL
the	NULL
ATL	NULL
patients	NULL
have	NULL
defective	NULL
provirus	NULL
that	NULL
lacks	NULL
5	NULL
``	NULL
regions	NULL
in	NULL
their	NULL
tumor	NULL
cells	NULL
``	NULL
``	NULL
(	NULL
Matsuoka	NULL
et	NULL
al	NULL
,	NULL
unpublished	NULL
observation	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
L-selectin	NULL
gene	NULL
is	NULL
constitutively	NULL
overexpressed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
HTLV-1	NULL
Tax	NULL
in	NULL
vivo	NULL
.	NULL

This	NULL
finding	NULL
implies	NULL
that	NULL
there	NULL
is	NULL
another	NULL
mechanism	NULL
independent	NULL
of	NULL
HTLV-1	NULL
Tax	NULL
underlying	NULL
the	NULL
overexpression	NULL
of	NULL
L-selectin	NULL
in	NULL
fresh	NULL
ATL	NULL
cells	NULL
.	NULL

The	NULL
1000000	NULL
~	NULL
o	NULL
©	NULL
a	NULL
€	NULL
100000	NULL
3	NULL
a	NULL
a	NULL
5	NULL
.	NULL

&	NULL
ad	NULL
3	NULL
10000	NULL
a	NULL
m	NULL
a	NULL
C	NULL
]	NULL
1000	NULL
-	NULL
a	NULL
a	NULL
1m	NULL
u	NULL
U	NULL
1	NULL
100	NULL
1000	NULL
10000	NULL
100000	NULL
sL-selectin	NULL
(	NULL
ng	NULL
/	NULL
ml	NULL
)	NULL
Fig	NULL
9	NULL
.	NULL

-	NULL
Correlation	NULL
between	NULL
the	NULL
levels	NULL
of	NULL
sL-selectin	NULL
and	NULL
those	NULL
of	NULL
sIL-2Ra	NULL
in	NULL
ATL	NULL
patients	NULL
.	NULL

The	NULL
results	NULL
from	NULL
25	NULL
samples	NULL
of	NULL
ATL	NULL
patients	NULL
are	NULL
plotted	NULL
.	NULL

The	NULL
correlation	NULL
coefficient	NULL
was	NULL
.6	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3116	NULL
same	NULL
notion	NULL
could	NULL
be	NULL
applied	NULL
to	NULL
other	NULL
Tax-responsive	NULL
genes	NULL
such	NULL
as	NULL
IL-2Ra	NULL
,	NULL
PTHrP	NULL
,	NULL
and	NULL
transforming	NULL
growth	NULL
factor	NULL
#	NULL
that	NULL
are	NULL
overexpressed	NULL
in	NULL
fresh	NULL
ATL	NULL
cells	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
we	NULL
showed	NULL
the	NULL
constitutive	NULL
overexpression	NULL
of	NULL
the	NULL
L-selectin	NULL
gene	NULL
in	NULL
ATL	NULL
cells	NULL
in	NULL
vivo	NULL
that	NULL
can	NULL
be	NULL
transactivated	NULL
by	NULL
HTLV-1	NULL
Tax	NULL
that	NULL
provided	NULL
another	NULL
clue	NULL
to	NULL
understanding	NULL
the	NULL
pathogenesis	NULL
of	NULL
organ	NULL
infiltration	NULL
of	NULL
ATL	NULL
cells	NULL
.	NULL

ACKNOWLEDGMENT	NULL
We	NULL
thank	NULL
Drs	NULL
I	NULL
Miyoshi	NULL
(	NULL
Kochi	NULL
Medical	NULL
School	NULL
,	NULL
Kochi	NULL
,	NULL
Japan	NULL
)	NULL
and	NULL
K.	NULL
Sugamura	NULL
(	NULL
Tohoku	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Sendai	NULL
,	NULL
Japan	NULL
)	NULL
for	NULL
the	NULL
gifts	NULL
of	NULL
MT-1	NULL
and	NULL
JPX9	NULL
,	NULL
respectively	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Uchiyama	NULL
T	NULL
,	NULL
Yodoi	NULL
J	NULL
,	NULL
Sagawa	NULL
K	NULL
,	NULL
Takatsuki	NULL
K	NULL
,	NULL
Uchino	NULL
H	NULL
:	NULL
Adult	NULL
T	NULL
cell	NULL
leukemia	NULL
:	NULL
Clinical	NULL
and	NULL
hematological	NULL
features	NULL
of	NULL
16	NULL
cases	NULL
.	NULL

Blood	NULL
50:481	NULL
,	NULL
1977	NULL
2	NULL
.	NULL

Poiesz	NULL
BJ	NULL
,	NULL
Ruscetti	NULL
FW	NULL
,	NULL
Gazdar	NULL
AF	NULL
,	NULL
Bunn	NULL
PA	NULL
,	NULL
Gallo	NULL
RC	NULL
:	NULL
Detection	NULL
and	NULL
isolation	NULL
of	NULL
type	NULL
C	NULL
retrovirus	NULL
particles	NULL
from	NULL
fresh	NULL
and	NULL
cultured	NULL
lymphocytes	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
cutaneous	NULL
T-cell	NULL
lymphoma	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
77:7415	NULL
,	NULL
1980	NULL
3	NULL
.	NULL

Yoshida	NULL
M	NULL
,	NULL
Miyoshi	NULL
I	NULL
,	NULL
Hinuma	NULL
Y	NULL
:	NULL
Isolation	NULL
and	NULL
characterization	NULL
of	NULL
retrovirus	NULL
from	NULL
cell	NULL
lines	NULL
of	NULL
human	NULL
adult	NULL
T	NULL
cell	NULL
leukemia	NULL
and	NULL
its	NULL
implication	NULL
in	NULL
the	NULL
disease	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
79:2031	NULL
,	NULL
1982	NULL
4	NULL
.	NULL

Shimoyama	NULL
M	NULL
,	NULL
and	NULL
the	NULL
Lymphoma	NULL
Study	NULL
Group	NULL
:	NULL
Diagnostic	NULL
criteria	NULL
and	NULL
classification	NULL
of	NULL
clinical	NULL
subtypes	NULL
of	NULL
adult	NULL
T-cell	NULL
leukaemia-lymphoma	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
79:428	NULL
,	NULL
1991	NULL
5	NULL
.	NULL

Takatsuki	NULL
K	NULL
,	NULL
Yamaguchi	NULL
K	NULL
,	NULL
Watanabe	NULL
T	NULL
,	NULL
Manabu	NULL
M	NULL
,	NULL
Kiyokawa	NULL
T	NULL
,	NULL
Mori	NULL
S	NULL
,	NULL
Miyata	NULL
N	NULL
:	NULL
Adult	NULL
T-cell	NULL
leukemia	NULL
and	NULL
HTLV-1	NULL
related	NULL
diseases	NULL
,	NULL
in	NULL
Takatsuki	NULL
K	NULL
,	NULL
Hinuma	NULL
Y	NULL
,	NULL
Yoshida	NULL
M	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Gann	NULL
Monograph	NULL
on	NULL
Cancer	NULL
Research	NULL
No	NULL
,	NULL
39	NULL
.	NULL

Advances	NULL
in	NULL
Adult	NULL
T-Cell	NULL
Leukemia	NULL
and	NULL
HTLV-1	NULL
Research	NULL
.	NULL

Boca	NULL
Raton	NULL
,	NULL
FL	NULL
,	NULL
CRC	NULL
,	NULL
1992	NULL
,	NULL
p	NULL
1	NULL
6	NULL
.	NULL

Gessain	NULL
A	NULL
,	NULL
Barin	NULL
F	NULL
,	NULL
Vernant	NULL
JC	NULL
,	NULL
Gout	NULL
O	NULL
,	NULL
Calender	NULL
A	NULL
,	NULL
de	NULL
The	NULL
G	NULL
:	NULL
Antibodies	NULL
to	NULL
human	NULL
T	NULL
lymphotropic	NULL
virus	NULL
type-l	NULL
in	NULL
patients	NULL
with	NULL
tropical	NULL
spastic	NULL
paraparesis	NULL
.	NULL

Lancet	NULL
2:407	NULL
,	NULL
1985	NULL
7	NULL
.	NULL

Osame	NULL
M	NULL
,	NULL
Usuku	NULL
K	NULL
,	NULL
Izumo	NULL
S	NULL
,	NULL
Tjichi	NULL
N	NULL
,	NULL
Amitani	NULL
H	NULL
,	NULL
Igata	NULL
A	NULL
:	NULL
HTLV-1	NULL
associated	NULL
myelopathy	NULL
,	NULL
a	NULL
new	NULL
clinical	NULL
entity	NULL
.	NULL

Lancet	NULL
1:1031	NULL
,	NULL
1986	NULL
8	NULL
.	NULL

Mochizuki	NULL
M	NULL
,	NULL
Watanabe	NULL
T	NULL
,	NULL
Yamaguchi	NULL
K	NULL
,	NULL
Takatsuki	NULL
K	NULL
,	NULL
Yoshi-mura	NULL
K	NULL
,	NULL
Shirao	NULL
M	NULL
,	NULL
Nakashima	NULL
S	NULL
,	NULL
Mori	NULL
S	NULL
,	NULL
Araki	NULL
S	NULL
,	NULL
Miyata	NULL
N	NULL
:	NULL
HTL-1	NULL
uveitis	NULL
:	NULL
A	NULL
distinct	NULL
clinical	NULL
entity	NULL
caused	NULL
by	NULL
HTLV-1	NULL
.	NULL

Jpn	NULL
J	NULL
Cancer	NULL
Res	NULL
83:236	NULL
,	NULL
1992	NULL
9	NULL
.	NULL

Mochizuki	NULL
M	NULL
,	NULL
Tajima	NULL
K	NULL
,	NULL
Watanabe	NULL
T	NULL
,	NULL
Yamaguchi	NULL
K	NULL
:	NULL
Human	NULL
T	NULL
lymphotropic	NULL
virus	NULL
type	NULL
1	NULL
uveitis	NULL
.	NULL

Br	NULL
J	NULL
Ophthalmol	NULL
78:149	NULL
,	NULL
1994	NULL
10	NULL
.	NULL

Sugimoto	NULL
M	NULL
,	NULL
Nakashima	NULL
H	NULL
,	NULL
Watanabe	NULL
S	NULL
,	NULL
Uyama	NULL
E	NULL
,	NULL
Tanaka	NULL
F	NULL
,	NULL
Ando	NULL
M	NULL
,	NULL
Araki	NULL
S	NULL
,	NULL
Kawasaki	NULL
S	NULL
:	NULL
T-lymphocyte	NULL
alveolitis	NULL
in	NULL
HTLV-I/associated	NULL
myelopathy	NULL
.	NULL

Lancet	NULL
2:1220	NULL
,	NULL
1987	NULL
11	NULL
.	NULL

LaGrenade	NULL
L	NULL
,	NULL
Hanchard	NULL
B	NULL
,	NULL
Fletcher	NULL
V	NULL
,	NULL
Cranston	NULL
B	NULL
,	NULL
Blattner	NULL
W	NULL
:	NULL
Infective	NULL
dermatitis	NULL
of	NULL
Jamaican	NULL
children	NULL
:	NULL
A	NULL
marker	NULL
for	NULL
HTLV-1	NULL
infection	NULL
.	NULL

Lancet	NULL
336:1345	NULL
,	NULL
1990	NULL
12	NULL
.	NULL

Iwasaki	NULL
Y	NULL
,	NULL
Ohara	NULL
Y	NULL
,	NULL
Kobayashi	NULL
I	NULL
,	NULL
Akizuki	NULL
S	NULL
:	NULL
Infiltration	NULL
of	NULL
helper/inducer	NULL
T	NULL
lymphocytes	NULL
heralds	NULL
central	NULL
nervous	NULL
system	NULL
damage	NULL
in	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
infection	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
140:1003	NULL
,	NULL
1992	NULL
13	NULL
.	NULL

Watanabe	NULL
T	NULL
,	NULL
Ono	NULL
A	NULL
,	NULL
Mochizuki	NULL
M	NULL
,	NULL
Yamaguchi	NULL
K	NULL
,	NULL
Araki	NULL
S	NULL
,	NULL
Miyata	NULL
N	NULL
:	NULL
Analysis	NULL
of	NULL
the	NULL
infiltrating	NULL
cells	NULL
of	NULL
HTLV-1	NULL
uveitis	NULL
.	NULL

AIDS	NULL
Res	NULL
Hum	NULL
Retroviruses	NULL
10:444	NULL
,	NULL
1994	NULL
(	NULL
abstr	NULL
)	NULL
14	NULL
.	NULL

Bevilacqua	NULL
MP	NULL
,	NULL
Nelson	NULL
RM	NULL
:	NULL
Selectins	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
91:379	NULL
,	NULL
1993	NULL
15	NULL
.	NULL

Lawrence	NULL
MB	NULL
,	NULL
Springer	NULL
TA	NULL
:	NULL
Leukocyte	NULL
roll	NULL
on	NULL
a	NULL
selectin	NULL
at	NULL
TATEWAKI	NULL
ET	NULL
AL	NULL
physiologic	NULL
flow	NULL
rates	NULL
:	NULL
Distinction	NULL
from	NULL
and	NULL
prerequisite	NULL
for	NULL
adhesion	NULL
through	NULL
integrins	NULL
.	NULL

Cell	NULL
65:859	NULL
,	NULL
1991	NULL
16	NULL
.	NULL

Jung	NULL
TM	NULL
,	NULL
Dailey	NULL
MO	NULL
:	NULL
Rapid	NULL
modulation	NULL
of	NULL
homing	NULL
receptors	NULL
(	NULL
gpI0Mel-14	NULL
)	NULL
induced	NULL
by	NULL
activators	NULL
of	NULL
protein	NULL
kinase	NULL
C.	NULL
Receptor	NULL
shedding	NULL
due	NULL
to	NULL
accelerated	NULL
proteolytic	NULL
cleavage	NULL
at	NULL
the	NULL
cell	NULL
surface	NULL
.	NULL

J	NULL
Immunol	NULL
144:3130	NULL
,	NULL
1990	NULL
17	NULL
.	NULL

Camerini	NULL
D	NULL
,	NULL
James	NULL
SP	NULL
,	NULL
Stamenkovic	NULL
I	NULL
,	NULL
Seed	NULL
B	NULL
:	NULL
is	NULL
the	NULL
human	NULL
equivalent	NULL
of	NULL
the	NULL
MEL-14	NULL
lymphnode	NULL
homing	NULL
receptor	NULL
.	NULL

Nature	NULL
342:78	NULL
,	NULL
1989	NULL
18	NULL
.	NULL

Watanabe	NULL
T	NULL
,	NULL
Song	NULL
Y	NULL
,	NULL
Hirayama	NULL
Y	NULL
,	NULL
Tamatani	NULL
T	NULL
,	NULL
Kuida	NULL
K	NULL
,	NULL
Miyasaka	NULL
M	NULL
:	NULL
Sequence	NULL
and	NULL
expression	NULL
of	NULL
a	NULL
rat	NULL
cDNA	NULL
for	NULL
LECAM-1	NULL
.	NULL

Biochim	NULL
Biophys	NULL
Acta	NULL
1131:321	NULL
,	NULL
1992	NULL
19	NULL
.	NULL

Kahn	NULL
J	NULL
,	NULL
Ingraham	NULL
RH	NULL
,	NULL
Shirley	NULL
F	NULL
,	NULL
Migaki	NULL
GI	NULL
,	NULL
Kishimoto	NULL
TK	NULL
:	NULL
Membrane	NULL
proximal	NULL
cleavage	NULL
of	NULL
L-selectin	NULL
:	NULL
Identification	NULL
of	NULL
the	NULL
cleavage	NULL
site	NULL
and	NULL
a	NULL
6-kD	NULL
transmembrane	NULL
peptide	NULL
fragment	NULL
of	NULL
L-selectin	NULL
.	NULL

J	NULL
Cell	NULL
Biol	NULL
125:461	NULL
,	NULL
1994	NULL
20	NULL
.	NULL

Schleiffenbaum	NULL
B	NULL
,	NULL
Spertini	NULL
0	NULL
,	NULL
Tedder	NULL
TF	NULL
:	NULL
Soluble	NULL
L-selectin	NULL
is	NULL
present	NULL
in	NULL
human	NULL
plasma	NULL
at	NULL
high	NULL
levels	NULL
and	NULL
retains	NULL
functional	NULL
activity	NULL
.	NULL

J	NULL
Cell	NULL
Biol	NULL
119	NULL
;	NULL
:229	NULL
,	NULL
1992	NULL
21	NULL
.	NULL

Fujisawa	NULL
J	NULL
,	NULL
Seiki	NULL
M	NULL
,	NULL
Kiyokawa	NULL
T	NULL
,	NULL
Yoshida	NULL
M	NULL
:	NULL
Functional	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
transacting	NULL
factor	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
82:2277	NULL
,	NULL
1985	NULL
22	NULL
.	NULL

Shimotohno	NULL
K	NULL
,	NULL
Takano	NULL
M	NULL
,	NULL
Teruuchi	NULL
T	NULL
,	NULL
Miwa	NULL
M	NULL
:	NULL
Requirement	NULL
of	NULL
multiple	NULL
copies	NULL
of	NULL
a	NULL
21-nucleotide	NULL
sequence	NULL
in	NULL
the	NULL
U3	NULL
region	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
and	NULL
type	NULL
II	NULL
long	NULL
terminal	NULL
repeats	NULL
for	NULL
trans-acting	NULL
activation	NULL
of	NULL
transcription	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
83:8112	NULL
,	NULL
1986	NULL
23	NULL
.	NULL

Jeang	NULL
KT	NULL
,	NULL
Boros	NULL
I	NULL
,	NULL
Brady	NULL
J	NULL
,	NULL
Radonovich	NULL
M	NULL
,	NULL
Khoury	NULL
G	NULL
:	NULL
Characterization	NULL
of	NULL
cellular	NULL
factors	NULL
that	NULL
interact	NULL
with	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
p40x-responsive	NULL
21-base-pair	NULL
sequence	NULL
.	NULL

J	NULL
Virol	NULL
62:4499	NULL
,	NULL
1988	NULL
24	NULL
.	NULL

Suzuki	NULL
T	NULL
,	NULL
Fujisawa	NULL
J	NULL
,	NULL
Toita	NULL
M	NULL
,	NULL
Yoshida	NULL
M	NULL
:	NULL
The	NULL
trans-activa-tor	NULL
tax	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
interacts	NULL
with	NULL
the	NULL
cAMP-responsive	NULL
element	NULL
CRE	NULL
binding	NULL
and	NULL
modulatory	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
21	NULL
base	NULL
pair	NULL
enhancer	NULL
of	NULL
HTLV-1	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:610	NULL
,	NULL
1993	NULL
25	NULL
.	NULL

Fujii	NULL
M	NULL
,	NULL
Niki	NULL
T	NULL
,	NULL
Mori	NULL
T	NULL
,	NULL
Matsuda	NULL
T	NULL
,	NULL
Matsui	NULL
M	NULL
,	NULL
Nomura	NULL
N	NULL
,	NULL
Seiki	NULL
M	NULL
:	NULL
HTLV-1	NULL
Tax	NULL
induces	NULL
expression	NULL
of	NULL
various	NULL
immediate	NULL
early	NULL
serum	NULL
responsive	NULL
genes	NULL
.	NULL

Oncogene	NULL
6:1023	NULL
,	NULL
1991	NULL
26	NULL
.	NULL

Watanabe	NULL
T	NULL
,	NULL
Yamaguchi	NULL
K	NULL
,	NULL
Takatsuki	NULL
K	NULL
,	NULL
Osame	NULL
M	NULL
,	NULL
Yoshida	NULL
M	NULL
:	NULL
Constitutive	NULL
expression	NULL
of	NULL
parathyroid	NULL
hormone-related	NULL
protein	NULL
gene	NULL
in	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
carriers	NULL
and	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
patients	NULL
that	NULL
can	NULL
be	NULL
trans-activated	NULL
by	NULL
HTLV-1	NULL
tax	NULL
gene	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
172:759	NULL
,	NULL
1990	NULL
27	NULL
.	NULL

Kim	NULL
SJ	NULL
,	NULL
Kebrl	NULL
JH	NULL
,	NULL
Burton	NULL
J	NULL
,	NULL
Tendler	NULL
CL	NULL
,	NULL
Jeang	NULL
KT	NULL
,	NULL
Dan-ielpour	NULL
D	NULL
,	NULL
Thevenin	NULL
C	NULL
,	NULL
Kim	NULL
KY	NULL
,	NULL
Sporn	NULL
MB	NULL
,	NULL
Roberts	NULL
AB	NULL
:	NULL
Transactivation	NULL
of	NULL
the	NULL
transforming	NULL
growth	NULL
factor	NULL
31	NULL
gene	NULL
by	NULL
human	NULL
T	NULL
lymphotropic	NULL
virus	NULL
type	NULL
1	NULL
Tax	NULL
:	NULL
A	NULL
potential	NULL
mechanism	NULL
for	NULL
the	NULL
increased	NULL
production	NULL
of	NULL
TGF-	NULL
$	NULL
1	NULL
in	NULL
adult	NULL
T	NULL
cell	NULL
leukemia	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
172:121	NULL
,	NULL
1990	NULL
28	NULL
.	NULL

Inoue	NULL
J	NULL
,	NULL
Seiki	NULL
M	NULL
,	NULL
Taniguchi	NULL
T	NULL
,	NULL
Tsuru	NULL
S	NULL
,	NULL
Yoshida	NULL
M	NULL
:	NULL
Induction	NULL
of	NULL
interleukin	NULL
2	NULL
receptor	NULL
gene	NULL
expression	NULL
by	NULL
p40	NULL
``	NULL
®	NULL
encoded	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

EMBO	NULL
J	NULL
5:2883	NULL
,	NULL
1986	NULL
29	NULL
.	NULL

Sodroski	NULL
J	NULL
:	NULL
The	NULL
human	NULL
T-cell	NULL
leukemia	NULL
(	NULL
HTLV	NULL
)	NULL
transactivator	NULL
(	NULL
Tax	NULL
)	NULL
protein	NULL
.	NULL

Biochim	NULL
Biophys	NULL
Acta	NULL
1114:19	NULL
,	NULL
1992	NULL
30	NULL
.	NULL

Uchiyama	NULL
T	NULL
,	NULL
Hori	NULL
T	NULL
,	NULL
Tsudo	NULL
M	NULL
,	NULL
Wano	NULL
Y	NULL
,	NULL
Umadome	NULL
H	NULL
,	NULL
Ta-mori	NULL
S	NULL
,	NULL
Yodoi	NULL
J	NULL
,	NULL
Maeda	NULL
M	NULL
,	NULL
Sawami	NULL
H	NULL
,	NULL
Uchino	NULL
H	NULL
:	NULL
Interleukin-2	NULL
receptor	NULL
(	NULL
Tac	NULL
antigen	NULL
)	NULL
expressed	NULL
on	NULL
adult	NULL
T	NULL
cell	NULL
leukemia	NULL
cells	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
76:446	NULL
,	NULL
1985	NULL
31	NULL
.	NULL

Shirono	NULL
K	NULL
,	NULL
Hattori	NULL
T	NULL
,	NULL
Hata	NULL
H	NULL
,	NULL
Nishimura	NULL
H	NULL
,	NULL
Takatsuki	NULL
K	NULL
;	NULL
Profiles	NULL
of	NULL
expression	NULL
of	NULL
activated	NULL
cells	NULL
antigens	NULL
on	NULL
peripheral	NULL
blood	NULL
and	NULL
lymph	NULL
node	NULL
cells	NULL
from	NULL
different	NULL
clinical	NULL
stages	NULL
of	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
.	NULL

Blood	NULL
73:1664	NULL
,	NULL
1989	NULL
32	NULL
.	NULL

Ishikawa	NULL
T	NULL
,	NULL
Imura	NULL
A	NULL
,	NULL
Tanaka	NULL
K	NULL
,	NULL
Shirane	NULL
H	NULL
,	NULL
Okuma	NULL
M	NULL
,	NULL
Uchiyama	NULL
T	NULL
:	NULL
E-selectin	NULL
and	NULL
vascular	NULL
adhesion	NULL
molecule-1	NULL
mediate	NULL
adult	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

OVEREXPRESSION	NULL
OF	NULL
L-SELECTIN	NULL
IN	NULL
ATL	NULL
T-cell	NULL
leukemia	NULL
cell	NULL
adhesion	NULL
to	NULL
endothelial	NULL
cells	NULL
.	NULL

Blood	NULL
82:1590	NULL
,	NULL
1993	NULL
33	NULL
.	NULL

Yamaguchi	NULL
K	NULL
,	NULL
Seiki	NULL
M	NULL
,	NULL
Yoshida	NULL
M	NULL
,	NULL
Nishimura	NULL
H	NULL
,	NULL
Kawano	NULL
F	NULL
,	NULL
Takatsuki	NULL
K	NULL
:	NULL
The	NULL
detection	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
proviral	NULL
DNA	NULL
and	NULL
its	NULL
application	NULL
for	NULL
classification	NULL
and	NULL
diagnosis	NULL
of	NULL
T-cell	NULL
malignancy	NULL
.	NULL

Blood	NULL
63:1235	NULL
,	NULL
1984	NULL
34	NULL
.	NULL

Nagata	NULL
K	NULL
,	NULL
Ohtani	NULL
K	NULL
,	NULL
Nakamura	NULL
M	NULL
,	NULL
Sugamura	NULL
K	NULL
:	NULL
Activation	NULL
of	NULL
endogenous	NULL
c-fos	NULL
proto-oncogene	NULL
expression	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I-encoded	NULL
p40tax	NULL
protein	NULL
in	NULL
the	NULL
human	NULL
T-cell	NULL
line	NULL
,	NULL
Jurkat	NULL
.	NULL

J	NULL
Virol	NULL
63:3220	NULL
,	NULL
1989	NULL
35	NULL
.	NULL

Miyoshi	NULL
I	NULL
,	NULL
Kubonishi	NULL
I	NULL
,	NULL
Sumida	NULL
M	NULL
,	NULL
Hiraki	NULL
S	NULL
,	NULL
Tsubota	NULL
T	NULL
,	NULL
Kimura	NULL
I	NULL
,	NULL
Miyamoto	NULL
K	NULL
,	NULL
Sato	NULL
J	NULL
;	NULL
:	NULL
A	NULL
novel	NULL
T-cell	NULL
line	NULL
derived	NULL
from	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
.	NULL

Gann	NULL
71:155	NULL
,	NULL
1980	NULL
36	NULL
.	NULL

Schleich	NULL
AB	NULL
,	NULL
Frick	NULL
M	NULL
,	NULL
Mayer	NULL
A	NULL
:	NULL
Patterns	NULL
of	NULL
invasive	NULL
growth	NULL
in	NULL
vitro	NULL
.	NULL

Human	NULL
decidua	NULL
graviditatis	NULL
confronted	NULL
with	NULL
established	NULL
human	NULL
cell	NULL
lines	NULL
and	NULL
primary	NULL
human	NULL
explants	NULL
.	NULL

J	NULL
Natl	NULL
Cancer	NULL
Inst	NULL
56:221	NULL
,	NULL
1976	NULL
37	NULL
.	NULL

Warnke	NULL
R	NULL
,	NULL
Levy	NULL
R	NULL
:	NULL
Detection	NULL
of	NULL
T	NULL
and	NULL
B	NULL
cell	NULL
antigens	NULL
with	NULL
hybridoma	NULL
monoclonal	NULL
antibodies	NULL
.	NULL

A	NULL
biotin-avidin-horseradish	NULL
per-oxidase	NULL
method	NULL
.	NULL

J	NULL
Histochem	NULL
Cytochem	NULL
27:771	NULL
,	NULL
1980	NULL
38	NULL
.	NULL

Berger	NULL
SL	NULL
,	NULL
Birkenmeier	NULL
CS	NULL
:	NULL
Inhibition	NULL
of	NULL
intractable	NULL
nucleases	NULL
with	NULL
ribonucleo-side-vanadyl	NULL
complexes	NULL
:	NULL
Isolation	NULL
of	NULL
messenger	NULL
ribonucleic	NULL
acid	NULL
from	NULL
resting	NULL
lymphocytes	NULL
.	NULL

Biochemistry	NULL
18:5143	NULL
,	NULL
1979	NULL
39	NULL
.	NULL

Karasuyama	NULL
H	NULL
,	NULL
Kudo	NULL
A	NULL
,	NULL
Melchers	NULL
F	NULL
:	NULL
The	NULL
proteins	NULL
encoded	NULL
by	NULL
the	NULL
VpreB	NULL
and	NULL
1	NULL
5	NULL
pre-B	NULL
cell-specific	NULL
genes	NULL
can	NULL
associate	NULL
with	NULL
each	NULL
other	NULL
and	NULL
with	NULL
&	NULL
heavy	NULL
chain	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
172:969	NULL
,	NULL
1990	NULL
40	NULL
.	NULL

Watanabe	NULL
T	NULL
,	NULL
Song	NULL
Y	NULL
,	NULL
Hirayama	NULL
Y	NULL
,	NULL
Tamatani	NULL
T	NULL
,	NULL
Kuida	NULL
K	NULL
,	NULL
Miyasaka	NULL
M	NULL
:	NULL
Sequence	NULL
and	NULL
expression	NULL
of	NULL
a	NULL
rat	NULL
cDNA	NULL
for	NULL
LECAM-1	NULL
.	NULL

Bioch	NULL
Biophys	NULL
Acta	NULL
1131:321	NULL
,	NULL
1992	NULL
41	NULL
.	NULL

Tateno	NULL
M	NULL
,	NULL
Kondo	NULL
N	NULL
,	NULL
Itoh	NULL
T	NULL
,	NULL
Chubachi	NULL
T	NULL
,	NULL
Togashi	NULL
T	NULL
,	NULL
Yoshiki	NULL
T	NULL
:	NULL
Rat	NULL
lymphoid	NULL
cell	NULL
lines	NULL
with	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
produc-tion	NULL
.	NULL

I	NULL
.	NULL

Biological	NULL
and	NULL
serological	NULL
characterization	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
159:1105	NULL
,	NULL
1984	NULL
42	NULL
.	NULL

Butcher	NULL
EC	NULL
,	NULL
Weissman	NULL
IL	NULL
:	NULL
Direct	NULL
fluorescent	NULL
labeling	NULL
of	NULL
cells	NULL
with	NULL
fluorescein	NULL
or	NULL
rhodamine	NULL
isothiocyanate	NULL
.	NULL

I	NULL
.	NULL

Technical	NULL
aspects	NULL
.	NULL

J	NULL
Immunol	NULL
Methods	NULL
37:97	NULL
,	NULL
1980	NULL
43	NULL
.	NULL

Ord	NULL
DC	NULL
,	NULL
Ernst	NULL
TJ	NULL
,	NULL
Zhou	NULL
L-J	NULL
,	NULL
Rambaldi	NULL
A	NULL
,	NULL
Spertini	NULL
O	NULL
,	NULL
Griffin	NULL
J	NULL
,	NULL
Tedder	NULL
TF	NULL
:	NULL
Structure	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
human	NULL
leukocyte	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
TQ-1	NULL
,	NULL
Leu8	NULL
)	NULL
of	NULL
lymphocytes	NULL
and	NULL
neutrophils	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
265:7760	NULL
,	NULL
1990	NULL
44	NULL
.	NULL

Sambrook	NULL
J	NULL
,	NULL
Fritsch	NULL
EF	NULL
,	NULL
Maniatis	NULL
T	NULL
:	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
(	NULL
ed	NULL
2	NULL
)	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
1989	NULL
45	NULL
.	NULL

Gorman	NULL
CM	NULL
,	NULL
Moffat	NULL
LF	NULL
,	NULL
Howard	NULL
BH	NULL
:	NULL
Recombinant	NULL
genomes	NULL
which	NULL
express	NULL
chloramphenicol	NULL
acetyltransferase	NULL
in	NULL
mammalian	NULL
ells	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
2:1044	NULL
,	NULL
1982	NULL
46	NULL
.	NULL

Kamihira	NULL
S	NULL
,	NULL
Atogami	NULL
S	NULL
,	NULL
Sohda	NULL
H	NULL
,	NULL
Momita	NULL
S	NULL
,	NULL
Yamada	NULL
Y	NULL
,	NULL
Tomonaga	NULL
M	NULL
:	NULL
Significance	NULL
of	NULL
soluble	NULL
interleukin-2	NULL
receptor	NULL
levels	NULL
for	NULL
evaluation	NULL
of	NULL
the	NULL
progression	NULL
of	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
.	NULL

Cancer	NULL
73:2753	NULL
,	NULL
1994	NULL
3117	NULL
47	NULL
.	NULL

Fukudome	NULL
K	NULL
,	NULL
Furuse	NULL
M	NULL
,	NULL
Fukuhara	NULL
N	NULL
,	NULL
Orita	NULL
S	NULL
,	NULL
Imai	NULL
T	NULL
,	NULL
Takagi	NULL
S	NULL
,	NULL
Nagira	NULL
M	NULL
,	NULL
Hinuma	NULL
Y	NULL
,	NULL
Yoshie	NULL
O	NULL
:	NULL
Strong	NULL
induction	NULL
of	NULL
ICAM-1	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
transformed	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
and	NULL
depression	NULL
of	NULL
ICAM-1	NULL
or	NULL
LFA-1	NULL
in	NULL
adult	NULL
T-cell-leukemia	NULL
derived	NULL
cell	NULL
lines	NULL
.	NULL

Int	NULL
J	NULL
Cancer	NULL
52:418	NULL
,	NULL
1992	NULL
48	NULL
.	NULL

Stibenz	NULL
D	NULL
,	NULL
Buhrer	NULL
C	NULL
:	NULL
Down-regulation	NULL
of	NULL
L-selectin	NULL
surface	NULL
expression	NULL
by	NULL
various	NULL
leukocyte	NULL
isolation	NULL
procedures	NULL
.	NULL

Scand	NULL
J	NULL
Immunol	NULL
39:59	NULL
,	NULL
1994	NULL
49	NULL
.	NULL

Kishimoto	NULL
TK	NULL
,	NULL
Jutila	NULL
MA	NULL
,	NULL
Berg	NULL
EL	NULL
,	NULL
Butcher	NULL
EC	NULL
:	NULL
Neutrophil	NULL
Mac-1	NULL
and	NULL
MEL-14	NULL
adhesion	NULL
proteins	NULL
inversely	NULL
regukated	NULL
by	NULL
che-motactic	NULL
factors	NULL
.	NULL

Science	NULL
245:1238	NULL
,	NULL
1989	NULL
50	NULL
.	NULL

Pietschmann	NULL
P	NULL
,	NULL
Cush	NULL
JJ	NULL
,	NULL
Lipsly	NULL
PE	NULL
,	NULL
Oppenheimer-Marks	NULL
N	NULL
:	NULL
Identification	NULL
of	NULL
subsets	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
capable	NULL
of	NULL
enhanced	NULL
trans-endothelial	NULL
migration	NULL
.	NULL

J	NULL
Immunol	NULL
149:1170	NULL
,	NULL
1992	NULL
51	NULL
.	NULL

Yamada	NULL
Y	NULL
,	NULL
Ichimaru	NULL
M	NULL
,	NULL
Shiku	NULL
H	NULL
:	NULL
Adult	NULL
T	NULL
cell	NULL
leukemia	NULL
cells	NULL
are	NULL
of	NULL
CD4+	NULL
CDw29+	NULL
T	NULL
cell	NULL
origin	NULL
and	NULL
secrete	NULL
a	NULL
B	NULL
cell	NULL
differentiation	NULL
factor	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
72:370	NULL
,	NULL
1989	NULL
52	NULL
.	NULL

Salahuddin	NULL
SZ	NULL
,	NULL
Markham	NULL
PD	NULL
,	NULL
Lindner	NULL
SG	NULL
,	NULL
Gootenberg	NULL
J	NULL
,	NULL
Popovic	NULL
M	NULL
,	NULL
Hemmi	NULL
H	NULL
,	NULL
Sarin	NULL
PS	NULL
,	NULL
Gallo	NULL
RC	NULL
:	NULL
Lymphokine	NULL
production	NULL
by	NULL
cultured	NULL
human	NULL
T	NULL
cells	NULL
transformed	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia-lymphoma	NULL
virus-I	NULL
.	NULL

Science	NULL
223:703	NULL
,	NULL
1984	NULL
53	NULL
.	NULL

Wano	NULL
Y	NULL
,	NULL
Hattori	NULL
T	NULL
,	NULL
Matuoka	NULL
M	NULL
,	NULL
Takatsuki	NULL
K	NULL
,	NULL
Chua	NULL
AO	NULL
,	NULL
Gubler	NULL
U	NULL
,	NULL
Greene	NULL
WC	NULL
:	NULL
Interleukin	NULL
1	NULL
gene	NULL
expression	NULL
in	NULL
adult	NULL
T	NULL
cell	NULL
leukemia	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
80:911	NULL
,	NULL
1987	NULL
54	NULL
.	NULL

Noma	NULL
T	NULL
,	NULL
Nakakubo	NULL
H	NULL
,	NULL
Sugita	NULL
M	NULL
,	NULL
Kumagai	NULL
S	NULL
,	NULL
Maeda	NULL
M	NULL
,	NULL
Shimizu	NULL
A	NULL
,	NULL
Honjo	NULL
T	NULL
:	NULL
Expression	NULL
of	NULL
different	NULL
combinations	NULL
of	NULL
in-terleukins	NULL
by	NULL
human	NULL
T	NULL
cell	NULL
leukemic	NULL
cell	NULL
lines	NULL
that	NULL
are	NULL
clonally	NULL
related	NULL
,	NULL
J	NULL
Exp	NULL
Med	NULL
169:1853	NULL
,	NULL
1989	NULL
55	NULL
.	NULL

Ohbo	NULL
K	NULL
,	NULL
Takasawa	NULL
N	NULL
,	NULL
Ishii	NULL
N	NULL
,	NULL
Tanaka	NULL
N	NULL
,	NULL
Nakamura	NULL
M	NULL
,	NULL
Sugamura	NULL
K	NULL
:	NULL
Functional	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
interleukin	NULL
2	NULL
receptor	NULL
y	NULL
chain	NULL
gene	NULL
promoter	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
270:7479	NULL
,	NULL
1995	NULL
56	NULL
.	NULL

Suzuki	NULL
T	NULL
,	NULL
Hirai	NULL
H	NULL
,	NULL
Fujisawa	NULL
J	NULL
,	NULL
Fujita	NULL
T	NULL
,	NULL
Yoshida	NULL
M	NULL
:	NULL
A	NULL
transactivator	NULL
Tax	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
binds	NULL
to	NULL
NF-kB	NULL
site	NULL
and	NULL
CArG	NULL
box	NULL
.	NULL

Oncogene	NULL
8:2391	NULL
,	NULL
1993	NULL
57	NULL
.	NULL

Bosselut	NULL
R	NULL
,	NULL
Duvall	NULL
JF	NULL
,	NULL
Gegonne	NULL
A	NULL
,	NULL
Bailly	NULL
M	NULL
,	NULL
Gemar	NULL
A	NULL
,	NULL
Brady	NULL
J	NULL
,	NULL
Ghysdael	NULL
J	NULL
:	NULL
The	NULL
product	NULL
of	NULL
the	NULL
c-ets-1	NULL
proto-oncogene	NULL
and	NULL
the	NULL
related	NULL
Ets2	NULL
protein	NULL
act	NULL
as	NULL
transcriptional	NULL
activators	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
HTLV-1	NULL
.	NULL

EMBO	NULL
J	NULL
9:3137	NULL
,	NULL
1990	NULL
58	NULL
.	NULL

Dittmer	NULL
J	NULL
,	NULL
Gitlin	NULL
SD	NULL
,	NULL
Reid	NULL
RL	NULL
,	NULL
Brady	NULL
JN	NULL
:	NULL
Transactivation	NULL
of	NULL
the	NULL
P2	NULL
promoter	NULL
of	NULL
parathyroid	NULL
hormone-related	NULL
protein	NULL
by	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
Tax1	NULL
:	NULL
Evidence	NULL
for	NULL
the	NULL
involvement	NULL
of	NULL
transcription	NULL
factor	NULL
Ets1	NULL
.	NULL

J	NULL
Virol	NULL
67:6087	NULL
,	NULL
1993	NULL
59	NULL
.	NULL

Oshima	NULL
K	NULL
,	NULL
Kikuchi	NULL
M	NULL
,	NULL
Masuda	NULL
Y	NULL
,	NULL
Kobari	NULL
S	NULL
,	NULL
Sumiyoshi	NULL
Y	NULL
,	NULL
Eguchi	NULL
F	NULL
,	NULL
Mohtai	NULL
H	NULL
,	NULL
Yoshida	NULL
T	NULL
,	NULL
Taleshita	NULL
M	NULL
,	NULL
Kimura	NULL
N	NULL
:	NULL
Defective	NULL
provirus	NULL
form	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
in	NULL
adult	NULL
T-cell	NULL
leukemia/lymphoma	NULL
:	NULL
Clinicopathological	NULL
features	NULL
.	NULL

Cancer	NULL
Res	NULL
51:4639	NULL
,	NULL
1991	NULL
60	NULL
.	NULL

Shimamoto	NULL
Y	NULL
,	NULL
Suga	NULL
K	NULL
,	NULL
Shibata	NULL
K	NULL
,	NULL
Matsuzaki	NULL
M	NULL
,	NULL
Yano	NULL
H	NULL
,	NULL
Yamaguchi	NULL
M	NULL
:	NULL
Clinical	NULL
importance	NULL
of	NULL
extraordinary	NULL
integration	NULL
patterns	NULL
of	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
proviral	NULL
DNA	NULL
in	NULL
adult	NULL
T-cell	NULL
leukemia/lymphoma	NULL
.	NULL

Blood	NULL
84:853	NULL
,	NULL
1994	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blOOd	NULL
1995	NULL
86	NULL
:	NULL
3109-3117	NULL
Constitutive	NULL
overexpression	NULL
of	NULL
the	NULL
L-selectin	NULL
gene	NULL
in	NULL
fresh	NULL
leukemic	NULL
cells	NULL
of	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
that	NULL
can	NULL
be	NULL
transactivated	NULL
by	NULL
human	NULL
T-cell	NULL
Iymphotropic	NULL
virus	NULL
type	NULL
1	NULL
Tax	NULL
A	NULL
_	NULL
48	NULL
o	NULL
6	NULL
'	NULL
t	NULL
“	NULL
f.9	NULL
'	NULL
.	NULL
'	NULL

e	NULL
>	NULL
\	NULL
/	NULL
{	NULL
®	NULL
M	NULL
Tatewaki	NULL
,	NULL
K	NULL
Yamaguchi	NULL
,	NULL
M	NULL
Matsuoka	NULL
,	NULL
T	NULL
Ishii	NULL
,	NULL
M	NULL
Miyasaka	NULL
,	NULL
S	NULL
Mori	NULL
,	NULL
K	NULL
Takatsuki	NULL
and	NULL
T	NULL
Watanabe	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/86/8/3109.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

